Undergraduate BIOL301 ⭐ 3 Credits Semester 5

Microbiology: Structure, Physiology, and Genetics of Microorganisms

A comprehensive survey of microbial life: bacterial cell structure, metabolism, and genetics; virology; microbial ecology; and an introduction to host-pathogen interactions. Essential for understanding expression systems used in peptide production (E. coli, yeast) and the roles of microbial peptides in biology.

📅 Studied by Skipper on 2026-10-01

📖 Core Concepts

Claude Opus 5.5

BIOL301 — Core Concepts: Microbiology: Structure, Physiology, and Genetics of Microorganisms

Personal study notes for Skipper. Primary reference: Madigan, Bender, Buckley, Sattley & Stahl, Brock Biology of Microorganisms, 16th ed. (Pearson, 2021), cited as [Madigan et al., 2021]. Key paper: K. A. Brogden, "Antimicrobial Peptides: Pore Formers or Metabolic Inhibitors in Bacteria?" Nature Reviews Microbiology 3, 238–250 (2005), DOI: 10.1038/nrmicro1098, cited as [Brogden, 2005].

0. Conceptual Introduction: What Is Microbiology Really About?

Microbiology is often taught as a catalogue: the names of organisms, the parts of a cell, a list of antibiotics. That framing hides what the subject is about. A better one is this: microbiology is the study of what life does when it is very small, very fast, and very numerous. Almost every distinctive feature of microbes follows from those three facts.

  • Small means a high surface-area-to-volume ratio. For a sphere, SA/V = 3/r. An E. coli cell (about 1 µm across) has roughly 10–100 times more membrane per unit volume than a typical eukaryotic cell. Nutrient uptake, energy conservation, and waste export are all limited by membrane area, so a small cell can run its metabolism very fast. This is why the cell envelope dominates microbiology. It is where the organism meets its world, where it makes most of its ATP, and where nearly every antibiotic and antimicrobial peptide attacks.
  • Fast means generation times of minutes to hours. A single E. coli doubling every 20 minutes would, in principle, give 272 ≈ 5 × 1021 cells in 24 hours. In practice nutrients run out long before that. You have seen exponential functions in MATH101/102; microbiology is where they become physically real.
  • Numerous means large populations with constant genetic variation. A culture of 109 cells with a mutation rate of about 10−9 per base per generation will, on average, contain a mutant at almost every position in its genome. Add horizontal gene transfer, in which genes move between unrelated cells, and the bacterial genome looks less like a fixed blueprint and more like a shared library. This is the root of the antimicrobial resistance crisis.

A second unifying idea comes straight from your CHEM102 and CHEM301 thermodynamics. Microbes are the universe's most inventive exploiters of redox chemistry. Animals essentially have one metabolic strategy: oxidize organic carbon with O2. Microbes can extract free energy from almost any thermodynamically favorable electron transfer, including H2 + SO42−, Fe2+ + O2, NH4+ + NO2−, and light-driven reactions. If ΔG < 0 and the rate is not too slow, some microbe has probably learned to live on it [Madigan et al., 2021]. Microbial metabolism is applied electrochemistry, and the Nernst equation is one of its central tools.

Third, microbes are our best molecular machines and model systems. Much of molecular biology (BIOL201) was worked out in E. coli and its phages: the genetic code, the operon, DNA replication, restriction enzymes. Today, E. coli and S. cerevisiae are factories for producing proteins and peptides. This course therefore spans ecology, physiology, genetics, and biotechnology, joined by the chemistry of one small cell.

"Small" changes the physics; "fast" changes the mathematics; "numerous" changes the evolution. Keep those three words in mind and most of microbiology becomes predictable rather than memorized.

1. Microbial Diversity and the Three-Domain Tree: Reading History in rRNA

Before the 1970s, prokaryotes were classified by shape, staining, and metabolism. These traits are easily altered by convergent evolution and horizontal gene transfer. Carl Woese's breakthrough was to classify cells by a molecule that every cell has and that cannot change much: the RNA of the small ribosomal subunit (16S rRNA in prokaryotes, 18S in eukaryotes) [Woese & Fox, 1977]. Comparing these sequences revealed that the "prokaryotes" were actually two deeply separate lineages. The result was the three-domain system: Bacteria, Archaea, and Eukarya [Woese, Kandler & Wheelis, 1990].

Why 16S rRNA is a good "molecular chronometer"

  1. Universal. Every cellular organism translates proteins on ribosomes, so every cell has the gene.
  2. Functionally constrained. The rRNA is the catalytic and structural core of the ribosome, since the peptidyl transferase center is RNA. Most mutations are harmful, so the sequence changes slowly.
  3. A mosaic of conserved and variable regions. Conserved stretches allow "universal" PCR primers that bind to nearly all bacteria. The nine hypervariable regions (V1–V9) between them carry information that distinguishes taxa. In effect, the gene comes with its own primer sites.
  4. Rarely transferred horizontally. rRNA must interact with dozens of ribosomal proteins, so a foreign copy usually works poorly. This makes 16S a relatively reliable record of vertical descent.

In practice, sequences are aligned, a distance matrix or likelihood model is computed, and a phylogenetic tree is inferred. Your MATH201 statistics is relevant here: tree-building is a statistical estimation problem, with bootstrap values as confidence measures. Historically, ~97% 16S identity was used as a rough threshold for "same species" (operational taxonomic units). Modern pipelines increasingly use exact amplicon sequence variants and whole-genome measures such as average nucleotide identity [Madigan et al., 2021].

What distinguishes Archaea

Archaea look like bacteria under a microscope, but their molecular machinery is a mix of bacterial and eukaryotic features:

  • Membrane lipids: isoprenoid chains joined to glycerol-1-phosphate by ether bonds. Bacteria and eukaryotes use fatty acids ester-linked to glycerol-3-phosphate, the opposite stereochemistry. Some archaea have tetraether lipids that span the whole membrane as a monolayer, which helps them survive at high temperature. From CHEM201: ethers resist hydrolysis far better than esters.
  • No peptidoglycan. Some archaea have pseudomurein, with N-acetyltalosaminuronic acid and β-1,3 linkages, so lysozyme and penicillin do not affect them. Many have only a protein S-layer.
  • Information processing resembles Eukarya: multi-subunit RNA polymerase, TATA-binding protein, histones in many lineages, and initiator methionine (not formyl-Met).

Something to notice: most microbial diversity has never been grown in culture. Sequencing 16S genes straight from environmental DNA (metagenomics) showed that cultured species are a small fraction of what exists, the so-called "great plate count anomaly." Molecular methods revealed a living world we had largely missed.

2. The Prokaryotic Cell Envelope: A Pressure Vessel Made of Sugar and Peptide

Analogy: a bacterium is like an inflated bicycle inner tube (the cytoplasmic membrane) inside a woven tire (the peptidoglycan sac). The cytoplasm holds high concentrations of solutes, so water flows in by osmosis and pushes the membrane outward. Recall the van 't Hoff relation from CHEM102:

π = i · M · R · T

With an internal–external solute difference of ~0.3 osmol/L at 310 K:
π ≈ (0.3 mol/L)(0.08206 L·atm·mol⁻¹·K⁻¹)(310 K) ≈ 7.6 atm

Estimates of turgor pressure vary. Gram-positive cells are often cited at around 15–25 atm, and Gram-negative cells at a few atm. Either way, it is far more than a lipid bilayer can withstand alone. Peptidoglycan is what keeps the cell from bursting. Anything that weakens it (lysozyme, β-lactams) causes osmotic lysis.

Peptidoglycan chemistry

  • Glycan backbone: alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM), linked β-1,4. Lysozyme cleaves the NAM–NAG β-1,4 bond.
  • Stem peptide on NAM: typically L-Ala–D-Glu (linked through its γ-carboxyl)–meso-diaminopimelic acid (Gram-negatives; L-Lys in many Gram-positives)–D-Ala. It is synthesized as a pentapeptide ending in D-Ala–D-Ala.
  • Cross-linking (transpeptidation): a penicillin-binding protein (PBP) cleaves the terminal D-Ala–D-Ala bond and forms a new peptide bond to the amino group on a neighboring stem. The released D-Ala leaves, so the energy of the old peptide bond pays for the new one. In S. aureus the bridge is a pentaglycine linker.
Transpeptidation (simplified):

PBP–Ser–OH + [stem]–D-Ala–D-Ala  →  PBP–Ser–O–C(=O)–D-Ala–[stem] + D-Ala     (acyl-enzyme)
PBP–Ser–O–C(=O)–D-Ala–[stem] + H₂N–[neighbor stem]  →  [stem]–D-Ala–C(=O)NH–[neighbor] + PBP–Ser–OH

The D-amino acids are surprising, since the ribosome uses only L-amino acids. Peptidoglycan peptides are made without the ribosome, by dedicated Mur ligases in the cytoplasm. This is a preview of non-ribosomal peptide chemistry. The D-configuration also protects against ordinary proteases, which are specific for L-peptides.

Gram-positive vs. Gram-negative

  • Gram-positive: thick peptidoglycan (20–80 nm, many layers), threaded with teichoic acids (anionic polyol-phosphate polymers) and lipoteichoic acids. In the Gram stain, the thick dehydrated wall traps the crystal violet–iodine complex when ethanol is applied.
  • Gram-negative: thin peptidoglycan (a few nm) in a periplasmic space, surrounded by an outer membrane. The outer membrane is asymmetric: phospholipid inner leaflet, lipopolysaccharide (LPS) outer leaflet. LPS consists of lipid A (endotoxin), core oligosaccharide, and O-antigen. Divalent cations (Mg2+, Ca2+) bridge the negatively charged phosphates of neighboring LPS molecules, forming a tightly packed layer that blocks hydrophobic molecules. Small hydrophilic molecules (< ~600 Da) pass through porins.

Connection to come: those cation bridges in LPS are exactly what cationic antimicrobial peptides and polymyxins displace. This is the "self-promoted uptake" mechanism discussed below.

Surface structures

  • Flagella: a helical filament (flagellin), a hook, and a basal-body rotary motor powered by ion flow across the membrane (H+ in E. coli, Na+ in some marine Vibrio). It is a true rotating machine, reaching hundreds of revolutions per second. Counterclockwise rotation bundles the flagella and the cell "runs"; clockwise rotation makes it "tumble." Chemotaxis works by changing how often the cell tumbles, a biased random walk. Bacteria live at very low Reynolds number (PHYS201 fluid concepts), where inertia is negligible. If the motor stops, the cell stops almost instantly, within a fraction of a nanometer of travel.
  • Pili / fimbriae: protein fibers for attachment. Type IV pili extend and retract for twitching motility and DNA uptake. Conjugative (F) pili bring mating cells together.
  • Capsule / slime layer: usually polysaccharide. It resists phagocytosis and drying out, and it is a major virulence factor (recall Griffith's smooth vs. rough pneumococci from BIOL102).
  • Endospores (Bacillus, Clostridium): highly resistant dormant cells. Their resistance comes from several features: a very dehydrated core; calcium dipicolinate, which helps immobilize water; small acid-soluble spore proteins (SASPs) that coat DNA, shift it toward an A-like form, and protect it from UV and heat damage; a thick cortex of modified peptidoglycan; and protein coats. Spores can remain viable for very long periods, so autoclaving (121 °C, saturated steam) is designed specifically to kill them.

3. Bacterial Growth Kinetics: Exponentials, Saturation, and the Chemostat

Bacteria divide by binary fission, so a population growing without limits follows simple exponential mathematics. This is the first-order kinetics of CHEM102, but with a positive rate constant.

Discrete form:        N = N₀ · 2ⁿ                 (n = number of generations)
Continuous form:      dN/dt = μN  ⟹  N(t) = N₀ e^{μt}

Generation (doubling) time:   g = ln 2 / μ ≈ 0.693 / μ
Number of generations:        n = (log N − log N₀) / log 2 ≈ 3.3 (log N − log N₀)

Here μ is the specific growth rate (h−1). Plot ln N against t and the exponential phase is a straight line with slope μ.

The batch growth curve

  1. Lag phase: cells are adjusting, making new enzymes and ribosomes for the new medium. The cells are busy even though the population is not growing yet.
  2. Exponential (log) phase: balanced growth with constant μ. All cellular components increase in proportion. Cells here are most uniform and most susceptible to many antibiotics, especially those targeting active processes like cell-wall synthesis.
  3. Stationary phase: a nutrient runs out or waste builds up, and growth rate equals death rate. Cells change their gene expression substantially (in E. coli, the alternative sigma factor RpoS), becoming smaller and more stress-resistant.
  4. Death phase: roughly exponential decline. Its tail is often complicated by "cryptic growth" on lysed neighbors and by persister cells.

Monod kinetics

Jacques Monod observed that growth rate depends on the limiting substrate concentration in a saturable, hyperbolic way [Monod, 1949]. The form is the same as Michaelis–Menten kinetics, although the basis is empirical rather than mechanistic:

μ = μ_max · S / (K_s + S)

μ_max = maximum specific growth rate
K_s   = substrate concentration at which μ = μ_max / 2

The chemostat: steady-state growth at a rate you choose

A chemostat [Monod, 1950; Novick & Szilard, 1950] continuously adds fresh medium (substrate concentration S0) at flow rate F into a culture of volume V, and removes culture at the same rate. The dilution rate is D = F/V. Mass balances on biomass X and substrate S, with yield coefficient Y (grams of cells per gram of substrate), give:

dX/dt = μX − DX
dS/dt = D(S₀ − S) − (μX)/Y

Steady state (dX/dt = 0, dS/dt = 0, X ≠ 0):

   μ = D                                    ← the key result
   S̄ = K_s · D / (μ_max − D)
   X̄ = Y (S₀ − S̄)

Washout occurs when D > μ_max · S₀ / (K_s + S₀)   (≈ μ_max for S₀ ≫ K_s)

Why this is notable: the experimenter sets the growth rate by turning a pump dial. The system regulates itself. If cells grow too fast, they consume substrate, S falls, μ falls, and the culture returns to μ = D. This is a stable fixed point, the kind of analysis you met with differential equations in MATH102. Chemostats let physiologists hold growth rate constant while changing one variable at a time. They are also used in experimental evolution, because sustained nutrient limitation selects for better uptake systems.

4. Microbial Metabolism: Electrons Falling Downhill

Every energy-conserving metabolism can be described by three choices [Madigan et al., 2021]:

  • Energy source: light (photo-), or chemicals (chemo-), either organic (chemoorganotroph) or inorganic (chemolithotroph).
  • Electron donor and acceptor: the redox couple that powers the process.
  • Carbon source: CO2 (autotroph) or organic carbon (heterotroph).

The redox tower

Arrange redox couples by standard reduction potential at pH 7 (E°′). Electrons release free energy when they pass from a couple higher on the list (more negative potential) to one lower down (more positive):

ΔG°′ = −n F ΔE°′        (F = 96.485 kJ·mol⁻¹·V⁻¹)

Selected E°′ (V):
  CO₂ / glucose          −0.43
  2H⁺ / H₂               −0.42
  NAD⁺ / NADH            −0.32
  CO₂ / CH₄              −0.24
  SO₄²⁻ / H₂S            −0.22
  fumarate / succinate   +0.03
  NO₃⁻ / NO₂⁻            +0.42
  Fe³⁺ / Fe²⁺ (pH 2)     +0.77
  ½O₂ / H₂O              +0.82

Example: NADH → O₂:  ΔE°′ = 0.82 − (−0.32) = 1.14 V
         ΔG°′ = −(2)(96.485)(1.14) ≈ −220 kJ/mol

This one table explains much of microbial ecology. In sediments, organisms use acceptors roughly in order of energy yield: O2, then nitrate, then Mn(IV)/Fe(III), then sulfate, then CO2 (methanogenesis). The result is distinct chemical layers in mud and soil, a thermodynamic sorting process carried out by organisms.

Two ways to make ATP

  1. Substrate-level phosphorylation: a high-energy phosphoryl donor (1,3-bisphosphoglycerate, phosphoenolpyruvate, acetyl phosphate) transfers its phosphate directly to ADP. This is the only ATP source in fermentation.
  2. Oxidative (and photo-) phosphorylation via the proton motive force: Mitchell's chemiosmotic theory [Mitchell, 1961]. Electron transport pumps protons out across the cytoplasmic membrane. In bacteria this is the plasma membrane, not a mitochondrion; recall that mitochondria descend from bacteria. The resulting electrochemical gradient drives ATP synthase, flagellar rotation, and many transporters.
Proton motive force:

Δp = Δψ − (2.303 RT / F) · ΔpH          (ΔpH = pH_in − pH_out)

At 25 °C:  2.303RT/F ≈ 59 mV per pH unit
Typical bacterial Δp ≈ −150 to −200 mV (interior negative and alkaline)

Free energy per mole H⁺ moved inward:  ΔG = F·Δp  ≈ −15 to −19 kJ/mol
Synthesizing ATP in vivo (~+50 kJ/mol) therefore requires ~3–4 H⁺ per ATP
(set by the number of c-subunits in the ATP synthase rotor).

Note that this is the same membrane-potential physics as PHYS202 (a capacitor with charge separated across about 5 nm of dielectric) combined with the concentration term from CHEM102's Nernst equation. Δp combines the two into a single quantity.

Fermentation: the redox-balance constraint

Without an external electron acceptor, a cell still has to reoxidize the NADH made in glycolysis, or glycolysis stops when NAD+ runs out. Fermentation solves this by passing electrons to an internal organic acceptor made from the substrate itself:

Homolactic:  Glucose → 2 Pyruvate (+2 NADH, +2 ATP) → 2 Lactate (−2 NADH)
             Net: C₆H₁₂O₆ → 2 CH₃CH(OH)COO⁻ + 2 H⁺      ΔG°′ ≈ −196 kJ/mol; 2 ATP

Alcoholic:   Pyruvate → acetaldehyde + CO₂ → ethanol (NADH reoxidized)

Mixed-acid (E. coli): lactate, acetate, succinate, ethanol, formate (→ H₂ + CO₂)

Fermentation is not "anaerobic respiration." The key rule is electron balance. The average oxidation state of carbon in the products must equal that of the substrate. Some products are more oxidized (CO2, acetate) and others more reduced (ethanol, H2). This is oxidation-state bookkeeping from CHEM101, applied to a living system.

Anaerobic respiration is different. It uses a full electron transport chain and a proton motive force, but the terminal acceptor is something other than O2 (NO3−, SO42−, fumarate, Fe3+, CO2). Since those acceptors have less positive E°′ than O2, the energy yield is lower, but still much higher than fermentation.

5. Bacterial Photosynthesis: Light Pumps Electrons Uphill

Photosynthesis reverses the redox tower. Light energy raises an electron from a donor with a positive potential to a very negative one. The electron then flows back down through an electron transport chain, producing a proton motive force, and in some organisms it also reduces NAD(P)+.

Oxygenic photosynthesis (cyanobacteria, and chloroplasts, which descend from them)

  • Two photosystems in series (PSII → PSI), the "Z-scheme."
  • Electron donor: H2O, oxidized at the Mn4CaO5 cluster of PSII. Water is a very poor donor (E°′ = +0.82 V), so two photons per electron are needed to reach NADP+ (−0.32 V).
  • Product: O2. Cyanobacteria caused the Great Oxidation Event about 2.4 billion years ago, the largest chemical change any organism has made to Earth.

Anoxygenic photosynthesis (purple bacteria, green sulfur bacteria, heliobacteria, etc.)

  • One photosystem only: type II-like (quinone-reducing) in purple bacteria, type I-like (Fe–S-reducing) in green sulfur bacteria and heliobacteria.
  • Pigments are bacteriochlorophylls, which absorb in the near-infrared (~800–1000 nm). This lets them use light that passes through layers of algae and cyanobacteria above them, a form of spectral niche partitioning.
  • Electron donors are easier to oxidize than water: H2S, S0, H2, Fe2+, organic compounds. No O2 is produced.
  • In purple bacteria, the reaction center (P870) is not reducing enough to reduce NAD+ directly. ATP comes from cyclic electron flow, and NADH comes from reverse electron transport, where the proton motive force drives electrons uphill. This shows that Δp is used in both directions.

The first atomic-resolution structure of a membrane protein was the purple bacterial reaction center of Rhodopseudomonas viridis (Deisenhofer, Huber and Michel; Nobel Prize 1988). This connects microbiology to the structural methods you learned in physical and analytical chemistry.

6. Nitrogen Fixation and Biosynthesis: Breaking the Triple Bond

N≡N has a bond dissociation energy of about 945 kJ/mol, and N2 is notoriously unreactive. Overall, N2 → NH3 is thermodynamically favorable with a good reductant. The difficulty is kinetic, a very high activation barrier, which is the kind of distinction emphasized in CHEM102. Industry overcomes it with the Haber–Bosch process (~400–500 °C, ~150–300 atm, Fe catalyst). Diazotrophic microbes do it at ambient temperature and pressure using nitrogenase:

N₂ + 8 H⁺ + 8 e⁻ + 16 MgATP  →  2 NH₃ + H₂ + 16 MgADP + 16 Pᵢ
  • Two components: the Fe protein (dinitrogenase reductase, NifH), which delivers electrons one at a time with ATP hydrolysis, and the MoFe protein (dinitrogenase), which holds the FeMo-cofactor (Fe7MoS9C plus homocitrate, with a central carbide) where N2 is reduced.
  • Obligatory H2 production: at least one H2 is released per N2 reduced. This appears to be built into the mechanism, not a defect.
  • O2 sensitivity: nitrogenase is irreversibly inactivated by O2. Aerobic diazotrophs protect it in different ways. Cyanobacteria such as Anabaena form heterocysts, specialized cells that lack PSII and have thick envelopes. Azotobacter uses very high respiration rates (respiratory protection). Rhizobia in legume nodules rely on leghemoglobin, a plant protein that buffers free O2.
  • Assay: nitrogenase also reduces acetylene to ethylene, which is easily measured by gas chromatography. This is the acetylene reduction assay, a direct link to your CHEM302 analytical work.

Assimilation: getting NH3 into biomolecules

Glutamine synthetase (GS):  Glutamate + NH₃ + ATP → Glutamine + ADP + Pᵢ        (high affinity)
GOGAT:                      Glutamine + α-ketoglutarate + NAD(P)H → 2 Glutamate
Glutamate dehydrogenase:    α-KG + NH₃ + NAD(P)H → Glutamate                    (low affinity; high [NH₃])

From glutamate and glutamine, transaminases spread nitrogen into the other amino acids. Biosynthesis is generally organized around about a dozen precursor metabolites taken from glycolysis, the pentose phosphate pathway, and the TCA cycle (e.g., pyruvate, oxaloacetate, α-ketoglutarate, erythrose-4-P). E. coli can make every amino acid, nucleotide, and lipid it needs from glucose and inorganic salts, an impressive range of synthetic ability for a single cell.

7. Horizontal Gene Transfer and Mobile DNA: The Genome as a Shared Library

In BIOL102 you studied vertical inheritance, from parent to offspring. Bacteria also exchange DNA horizontally between contemporaries, sometimes across distantly related species. Three classical mechanisms, plus one lab method:

(a) Transformation — taking up naked DNA

  • Discovered by Griffith (1928), and identified as DNA by Avery, MacLeod and McCarty [Avery, MacLeod & McCarty, 1944].
  • Natural competence is a regulated physiological state (in Streptococcus pneumoniae, controlled by a secreted peptide pheromone; in Bacillus subtilis, by the ComK regulon). DNA is bound by a type IV pilus-like apparatus, one strand is degraded, and the single strand that enters is integrated by RecA-mediated homologous recombination.
  • Artificial transformation in the lab: CaCl2-treated E. coli plus heat shock, or electroporation. In electroporation, a brief high-voltage pulse (field strength on the order of kV/cm) temporarily creates pores in the membrane. Electroporation works for many species with no natural competence.

(b) Conjugation — cell-to-cell transfer through a mating apparatus

  • Discovered by Lederberg and Tatum [Lederberg & Tatum, 1946].
  • The F (fertility) plasmid (~100 kb) encodes the F pilus and a type IV secretion system. A relaxase nicks the plasmid at oriT, and one strand is transferred 5′→3′ by rolling-circle replication. Both cells end up with double-stranded F, so F− × F+ → two F+ cells.
  • Hfr strains have F integrated into the chromosome, via recombination between shared insertion sequences. Transfer starts at oriT and pulls chromosomal genes along behind it in a fixed order. Because mating pairs usually break apart before the entire chromosome (about 100 minutes) is transferred, the recipient rarely becomes Hfr. Wollman and Jacob's interrupted mating experiments used a kitchen blender to separate pairs at set times, which produced the first E. coli chromosome map measured in "minutes." The unit is still used today.
  • F′ plasmids are excised F factors that carry adjacent chromosomal genes, making partial diploids. Jacob and Monod used these for cis/trans tests in the lac operon work you saw in BIOL201.

(c) Transduction — phage as an accidental courier

  • Discovered by Zinder and Lederberg [Zinder & Lederberg, 1952] with phage P22 in Salmonella.
  • Generalized transduction (P1, P22): during headful packaging, the phage sometimes packages host chromosomal DNA instead of its own genome. Any host gene can be transferred.
  • Specialized transduction (λ): an error in prophage excision carries along the genes next to the attachment site (gal or bio for λ). Only those specific genes can be transferred.

Transposable elements and site-specific recombination

  • Insertion sequences (IS elements): about 0.7–2.5 kb, containing only a transposase gene flanked by short inverted repeats. When an IS inserts, the target-site duplication produces short direct repeats of host DNA on either side.
  • Composite transposons (Tn5, Tn10): two IS elements flanking cargo genes, often antibiotic resistance. The two IS elements can move the whole segment as one unit. Think of two IS elements as handles on a suitcase of resistance genes.
  • Mechanisms: conservative ("cut-and-paste," e.g., Tn5, Tn10) or replicative (Tn3, phage Mu), which goes through a cointegrate resolved by a resolvase.
  • Site-specific recombination needs only short specific sequences, not extensive homology, and no RecA. Examples: λ integrase recombining attP × attB (with host IHF), Cre/loxP (a standard genetic engineering tool), and Hin inversion switching flagellar phase in Salmonella. Integrons use an integrase to capture promoterless "gene cassettes," building arrays of resistance genes, which is significant for multidrug resistance.
Resistance genes are often found inside transposons, inside integrons, on conjugative plasmids. This nested arrangement of mobile elements explains why resistance spreads between species far faster than point mutations could [Madigan et al., 2021].

8. Bacteriophages and Viruses: Genomes That Have Shed the Cell

Lytic vs. lysogenic: λ as a model genetic decision

T4 is strictly lytic. It injects DNA through a contractile tail (a molecular syringe), stops host transcription, degrades host DNA, replicates, and assembles about 100–200 progeny before lysing the cell with holin and endolysin. Its DNA contains 5-hydroxymethylcytosine, glucosylated, which protects it from its own nucleases and many host restriction systems.

Lambda (λ) is temperate. After infection it chooses between two outcomes:

  • Lysogeny: CI repressor binds the operators OR and OL, shutting off lytic genes. Integrase inserts the genome at attB as a prophage, which is copied along with the host chromosome.
  • Lysis: Cro binds the same operators with different relative affinities, repressing cI and allowing the lytic program to proceed.
  • The decision depends on CII, an activator of cI transcription that is degraded by the host protease FtsH. When many phages infect the same cell, or when the host is starved and FtsH activity is low, CII stabilizes and lysogeny is favored. The phage is effectively sensing whether hosts are scarce relative to phages.
  • Induction: DNA damage activates RecA (the SOS response), which stimulates CI to cleave itself. The prophage leaves a damaged host. This regulatory circuit was one of the founding examples of genetic switches in systems biology.

Phage therapy

Lytic phages that infect a specific pathogen can be used as self-amplifying antibacterial agents. Advantages: high host specificity (gut microbiota largely spared), replication at the infection site, and activity against antibiotic-resistant strains. Challenges: narrow host range (often requiring cocktails or personalized phages), rapid phage resistance (often via changes to surface receptors, which can carry a fitness cost or restore antibiotic susceptibility), immune clearance, and regulatory hurdles. Phage-derived endolysins (peptidoglycan hydrolases) are also being developed as protein antibacterials, especially against Gram-positives, whose peptidoglycan is directly exposed.

Viral replication strategies: the Baltimore logic

Every virus must eventually produce mRNA (+ sense) that host ribosomes can translate. David Baltimore classified viruses by how their genome is converted to mRNA:

I    dsDNA                → mRNA                            (herpesviruses, poxviruses, T4, λ)
II   ssDNA                → dsDNA → mRNA                    (parvoviruses, φX174)
III  dsRNA                → mRNA via viral RdRp             (reoviruses)
IV   (+)ssRNA             = mRNA directly; RdRp makes (−) template   (poliovirus, coronaviruses)
V    (−)ssRNA             → mRNA via packaged RdRp          (influenza, rabies, measles)
VI   (+)ssRNA-RT          → DNA (reverse transcriptase) → integrated provirus → mRNA   (HIV)
VII  dsDNA-RT             → pregenomic RNA → DNA            (hepatitis B)

A useful rule: if the genome cannot serve as mRNA and the cell has no enzyme to copy it, the virion must carry that enzyme. (−)ssRNA and dsRNA viruses package RNA-dependent RNA polymerase, and retroviruses package reverse transcriptase and integrase. This follows directly from the central dogma you studied in BIOL201.

Host cell entry: attachment is set by specific receptor binding (e.g., HIV gp120 to CD4 plus CCR5/CXCR4; influenza hemagglutinin to sialic acid), which determines host range and tissue tropism. Enveloped viruses fuse either at the plasma membrane (HIV, pH-independent) or after endocytosis (influenza, triggered by low endosomal pH). Fusion proteins fold back into a trimer-of-hairpins (six-helix bundle) structure that pulls the viral and cellular membranes together. Peptides that mimic one heptad repeat can block this rearrangement; enfuvirtide (T-20) is a 36-residue anti-HIV peptide that works this way. Non-enveloped viruses disrupt or penetrate membranes, and phages inject only their nucleic acid.

9. Antimicrobial Agents and Resistance: Molecular Targets and Countermoves

A good antibiotic exploits a difference between microbe and host. This is selective toxicity. The main targets are therefore structures bacteria have and humans lack (peptidoglycan), or that differ enough structurally (70S vs. 80S ribosomes, gyrase vs. human topoisomerase II).

Mechanisms of action

  • β-lactams (penicillins, cephalosporins, carbapenems): the strained four-membered β-lactam ring resembles the D-Ala–D-Ala end of the stem peptide. The PBP active-site serine attacks the β-lactam carbonyl and forms a stable acyl-enzyme that hydrolyzes very slowly. The PBP is effectively trapped, so these are mechanism-based inhibitors. Cell-wall hydrolases keep working while synthesis stops, leading to osmotic lysis. That is why β-lactams act mainly on growing cells. The ring's reactivity comes from strain and reduced amide resonance (the bicyclic geometry keeps the nitrogen lone pair from fully delocalizing into the carbonyl), which you can reason about with CHEM201/202.
  • Aminoglycosides (streptomycin, gentamicin, kanamycin): polycationic sugars that bind the 16S rRNA decoding site (A-site) of the 30S subunit and cause misreading. Mistranslated membrane proteins damage the membrane, which increases drug uptake in a damaging feedback loop. Uptake requires a proton motive force, so aminoglycosides are poorly active against anaerobes.
  • Fluoroquinolones (ciprofloxacin, levofloxacin): stabilize the DNA gyrase/topoisomerase IV–DNA cleavage complex after the DNA is cut, turning an essential enzyme into one that produces double-strand breaks. Gyrase is the main target in many Gram-negatives and topo IV in many Gram-positives.
  • Macrolides (erythromycin, azithromycin): bind the 23S rRNA in the 50S nascent peptide exit tunnel. Classically described as blocking elongation, they are now known to cause stalling that depends on the sequence of the nascent peptide. Some peptides can still pass the bound drug. This shows that the ribosome "reads" the peptide it is making.

Resistance mechanisms — four basic strategies

  1. Destroy or modify the drug: β-lactamases. Serine β-lactamases (Ambler classes A, C, D) are evolutionary relatives of PBPs. They form the same acyl-enzyme but then hydrolyze it rapidly. A PBP that evolved to deacylate efficiently became a resistance enzyme. Metallo-β-lactamases (class B, e.g., NDM-1) use Zn2+-activated water and inactivate nearly all β-lactams, including carbapenems. Clavulanate and avibactam are β-lactamase inhibitors. Aminoglycoside-modifying enzymes acetylate, phosphorylate, or adenylylate the drug.
  2. Alter the target: MRSA's mecA encodes PBP2a, which has low β-lactam affinity. Erm methyltransferases dimethylate A2058 of 23S rRNA, blocking macrolide binding. Point mutations in gyrA/parC confer fluoroquinolone resistance. Vancomycin resistance (VanA) is especially clear chemically: the cell rebuilds its stem peptide to end in D-Ala–D-Lac. Replacing an amide NH with an ester O removes one hydrogen bond and adds lone-pair repulsion, cutting vancomycin affinity by roughly 1000-fold. A single-atom change makes the drug largely ineffective.
  3. Pump the drug out: efflux pumps. In Gram-negatives, the RND-family tripartite pump AcrAB–TolC spans inner membrane, periplasm, and outer membrane and is driven by proton antiport. It has broad specificity and exports many structurally different drugs.
  4. Reduce entry: loss or mutation of porins (e.g., OprD loss in Pseudomonas → carbapenem resistance) and LPS modifications.

Also distinguish persistence from resistance: a small subpopulation of dormant cells survives killing without any genetic change, and its descendants are fully susceptible. Tolerance and persistence are increasingly understood as precursors that make it easier to evolve true resistance.

10. Antimicrobial Peptides (AMPs): The Membrane as Target

Long before humans made antibiotics, multicellular organisms produced small, cationic, amphipathic peptides as part of innate immunity [Zasloff, 2002]. Three classic families:

  • Cecropins — from the giant silk moth Hyalophora cecropia (Boman and colleagues; [Steiner et al., 1981]). About 35–39 residues, linear, forming two α-helices joined by a hinge: an amphipathic N-terminal helix and a more hydrophobic C-terminal helix.
  • Magainins — from the skin of Xenopus laevis [Zasloff, 1987]. 23 residues, unstructured in water but forming an amphipathic α-helix when it contacts a membrane. Zasloff reportedly started investigating after noticing that frogs healed from surgery without infection in non-sterile water.
  • Defensins — in mammals (α- and β-defensins), insects, and plants. About 18–45 residues with a β-sheet fold held together by three disulfide bonds. The constrained structure makes them stable against proteolysis.

Why bacteria and not us? The selectivity argument

  • Bacterial membranes are rich in anionic lipids (phosphatidylglycerol, cardiolipin) and are surrounded by anionic LPS or teichoic acids. The outer leaflet of mammalian plasma membranes is mostly zwitterionic (phosphatidylcholine, sphingomyelin) and contains cholesterol, which stiffens the bilayer and resists peptide insertion.
  • Bacteria maintain a strongly negative-inside membrane potential that can pull cationic peptides inward.
  • So the first step is electrostatic: positive charge (Lys, Arg) attracts the peptide to negative surfaces. In Gram-negatives, the peptides then displace the Mg2+/Ca2+ bridging LPS, loosening the outer membrane and admitting more peptide. This is "self-promoted uptake."

Models of membrane disruption [Brogden, 2005]

  1. Barrel-stave: helices insert perpendicular to the bilayer like barrel staves, hydrophobic faces toward the lipid tails and hydrophilic faces lining an aqueous channel. The best-supported example is alamethicin.
  2. Toroidal pore (wormhole): peptides insert and force the lipid monolayers to bend continuously through the pore, so the pore is lined by both peptide and lipid headgroups. Associated with magainin 2, protegrins, and melittin.
  3. Carpet model: peptides cover the membrane surface parallel to the bilayer. Above a threshold concentration they break it up in a detergent-like way, forming micelles [Shai, 1999]. Associated with cecropins and some other helical AMPs.

Brogden's review argues that membrane permeabilization is not the whole story. Many AMPs kill at concentrations that cause little or no measurable membrane damage. Some cross the membrane and act on intracellular targets: binding DNA/RNA (buforin II), inhibiting protein synthesis or chaperones (e.g., pyrrhocoricin and drosocin acting on DnaK), blocking cell-wall synthesis, or inhibiting enzymes. The title question, "pore formers or metabolic inhibitors?", has the answer: often both, depending on the peptide, the concentration, and the organism [Brogden, 2005]. Membrane interaction may be necessary as an entry step without being what kills the cell.

A key experiment: peptides synthesized entirely from D-amino acids (all-D cecropin A, magainin 2, melittin) are generally about as antibacterial as their natural L-forms [Wade et al., 1990]. A chiral protein receptor would not accept a mirror-image ligand. This result argues strongly that these peptides act on an achiral target, the lipid bilayer, rather than on a specific stereospecific receptor. It is a useful example of using stereochemistry to test a mechanism.

11. E. coli and Yeast as Protein Factories

E. coli expression systems

  • T7 system [Studier & Moffatt, 1986]: the target gene sits behind a promoter recognized only by bacteriophage T7 RNA polymerase. Strain BL21(DE3) carries the T7 RNAP gene on a λ prophage (DE3) under the IPTG-inducible lacUV5 promoter. Adding IPTG releases LacI, producing T7 RNAP, which then transcribes the target gene very efficiently. Expression can reach a large fraction of total cell protein. To limit leaky expression before induction: lac operators placed downstream of the T7 promoter (pET "T7lac"), plasmids encoding T7 lysozyme (pLysS), which inhibits T7 RNAP, and glucose for catabolite repression.
  • tac promoter [de Boer, Comstock & Vasser, 1983]: a hybrid of the trp promoter −35 region and the lacUV5 −10 region. It is strong, uses host σ70 RNA polymerase, and is IPTG-inducible through LacI. It requires no phage polymerase and is moderately strong, which can be useful when maximum expression would be toxic.
  • Inclusion bodies: overexpressed protein that cannot fold quickly enough forms dense, insoluble, partly structured aggregates. These are a problem (the protein must be solubilized in urea or guanidine-HCl and then refolded) and an advantage (high purity, protection from proteases, and toxic peptides are kept inactive). Lower growth temperature, weaker promoters, fusion partners (MBP, thioredoxin, SUMO), and co-expressed chaperones all increase soluble yield.
  • Periplasmic expression: the E. coli cytoplasm is reducing (thioredoxin and glutaredoxin systems), so disulfide bonds generally do not form there. The periplasm is oxidizing: DsbA introduces disulfides, and DsbC corrects mispaired ones. An N-terminal signal peptide (e.g., PelB, OmpA) directs the protein through the Sec translocon (unfolded) or Tat (folded). Benefits: correct disulfides, simpler purification (osmotic shock releases periplasmic contents), and a signal peptide removed cleanly by signal peptidase. Engineered strains such as Origami and SHuffle allow cytoplasmic disulfide formation.

Saccharomyces cerevisiae as a eukaryotic host

  • Advantages: GRAS status (generally recognized as safe), fast growth on cheap media, simple genetics (homologous recombination, stable haploid and diploid states), and a full eukaryotic secretory pathway (ER, Golgi) with PDI-assisted disulfide formation and chaperones. It also secretes few endogenous proteins, so secreted products are relatively clean.
  • Secretion: the classic leader is the α-mating factor prepro sequence. The pre region is an ER signal peptide. The pro region is removed in the late Golgi by the Kex2 protease, which cleaves after Lys-Arg. Human insulin precursors have been produced industrially this way.
  • Glycosylation caveat: yeast performs N-linked glycosylation (at Asn-X-Ser/Thr), but in the Golgi it adds high-mannose structures, sometimes hypermannosylation with dozens to over a hundred mannose residues. Human cells build complex glycans with sialic acid. Yeast glycans can be immunogenic and change pharmacokinetics. Glyco-engineered Pichia pastoris (now Komagataella phaffii) strains have been built that produce human-like glycans.

12. Connections to Peptide Chemistry

This course connects to peptide science in many places. Here are the links worth noting now; each will develop further in later courses:

  1. Peptidoglycan is a peptide polymer built outside the ribosome. Its D-amino acids, γ-linked glutamate, and transpeptidation chemistry are peptide-bond chemistry done by enzymes. Transpeptidation is aminolysis of an activated (acyl-enzyme) ester, the same logic as the active esters (HOBt/HATU-activated) used in solid-phase peptide synthesis. Nature and the synthetic chemist both form amide bonds by activating the carboxyl first.
  2. Many important antibiotics are peptides made by non-ribosomal peptide synthetases (NRPS). Examples: vancomycin (a glycopeptide that binds D-Ala–D-Ala through five hydrogen bonds), daptomycin (a cyclic lipopeptide that depends on Ca2+), polymyxin B/colistin (cationic cyclic lipopeptides that target lipid A), gramicidin, and bacitracin. Even penicillin starts as the NRPS-derived tripeptide δ-(L-α-aminoadipyl)-L-Cys-D-Val (ACV), which isopenicillin N synthase cyclizes into the β-lactam/thiazolidine core. NRPS assembly lines use modular adenylation, thiolation, and condensation domains, which allow D-amino acids, N-methylation, and macrocyclization.
  3. Ribosomally made, post-translationally modified peptides (RiPPs): lantibiotics such as nisin contain lanthionine thioether bridges and bind lipid II, the peptidoglycan precursor, both inhibiting wall synthesis and forming pores. This combines Section 2 and Section 10 in one molecule. The resistance mechanism of Section 9 applies too: lipid II's pyrophosphate is a harder target to modify than D-Ala–D-Ala.
  4. AMP design is quantitative structure–activity chemistry. For a helical peptide, the hydrophobic residues should cluster on one face. The Eisenberg hydrophobic moment quantifies amphipathicity [Eisenberg, Weiss & Terwilliger, 1982]:
    μ_H = | Σₙ Hₙ · e^{i n δ} |        (δ = 100° per residue for an α-helix; Hₙ = hydrophobicity of residue n)
        
    Designers adjust net charge (usually +2 to +9), hydrophobicity, helix propensity, and μH to balance antibacterial potency against hemolysis. Analytical chemistry from CHEM302 comes in directly: RP-HPLC retention time is a practical measure of peptide hydrophobicity, and circular dichroism shows coil-to-helix transitions on membrane binding.
  5. Stereochemistry as both a tool and a therapeutic strategy. All-D AMPs retain activity (Section 10) and are resistant to proteases, a major advantage for drug development. Retro-inverso peptides and peptoids follow from the same idea.
  6. Recombinant peptide production is microbial physiology. Making an AMP in E. coli means expressing a molecule designed to kill E. coli. Standard approaches include fusing it to a partner that drives it into inclusion bodies (sequestering it), or neutralizing it with an anionic fusion partner, followed by chemical (CNBr at Met, formic acid at Asp-Pro) or enzymatic (TEV, SUMO protease, enterokinase) release. Defensins need correct three-disulfide pairing, which requires periplasmic or yeast expression or oxidative refolding. Each choice in Section 11 is a choice in peptide chemistry.
  7. Peptides as signals: Gram-positive quorum sensing and competence (Section 7) depend on secreted, processed peptide pheromones (the CSP of S. pneumoniae, the thiolactone autoinducing peptides of S. aureus agr). Synthetic analogs that block these receptors are being studied as anti-virulence drugs that disarm bacteria without killing them, which may put less selective pressure toward resistance.

13. Common Misconceptions to Watch Out For

  • "Prokaryote" is not a phylogenetic group. Archaea and Bacteria are separate domains. Archaea share several information-processing features with Eukarya, and the eukaryotic host lineage likely arose from within the Archaea (Asgard archaea). "Prokaryote" describes a cell type, not a clade.
  • "Archaea are extremophiles." Many are, but archaea are abundant in oceans, soils, and the human gut. Thaumarchaeota are major ammonia oxidizers worldwide.
  • "Gram staining measures the outer membrane." The stain result reflects peptidoglycan thickness and how ethanol affects it. Some organisms stain Gram-variable, and mycobacteria (waxy mycolic acid envelopes) need acid-fast staining.
  • "Fermentation means any anaerobic metabolism." In the physiological sense, fermentation is redox-balanced metabolism using substrate-level phosphorylation and an internal electron acceptor. Anaerobic respiration uses an electron transport chain and an external acceptor. Industry uses "fermentation" loosely for any microbial culture; keep the two meanings separate.
  • "Bacteria have no organized internal structure." Bacteria have a cytoskeleton (FtsZ, MreB, crenactin in archaea), protein microcompartments (carboxysomes), magnetosomes, and spatially organized chromosomes.
  • "In a chemostat, cells grow at μmax." At steady state, μ = D, which is set by the operator. Cells grow at μmax only at the edge of washout. The steady-state substrate concentration depends on D, not on S0. S0 sets the biomass, not the residual substrate.
  • "Exponential growth means the population doubles at a constant number per hour." It is the fractional rate that stays constant. On a linear plot the curve looks flat and then suddenly vertical. Use a semilog plot.
  • "Bacteria become resistant because individual cells adapt to the drug." Resistance mostly arises from pre-existing genetic variants (shown by Luria–Delbrück fluctuation analysis) or from horizontally acquired genes, which antibiotics then select for. Physiological tolerance and persistence are real but are not inherited resistance.
  • "Antibiotics kill viruses." Antibacterial agents target bacterial structures (cell walls, 70S ribosomes, gyrase) that viruses lack. Antivirals target viral enzymes and steps such as reverse transcriptase, protease, polymerase, and fusion.
  • "Lysogeny is a dormant, inactive state." The prophage actively expresses CI, and often expresses lysogenic conversion genes that change the host. Cholera toxin, diphtheria toxin, and Shiga toxin genes are carried by phages.
  • "AMPs simply punch holes." Per [Brogden, 2005], many AMPs have intracellular targets, and membrane permeabilization may be only an entry step. Mechanism depends on peptide, concentration, and target cell. Bacteria also resist AMPs, for example by adding positively charged groups to lipid A (aminoarabinose) or to teichoic acids (D-alanylation via dlt), lysinylating phosphatidylglycerol (MprF), and by using proteases and efflux pumps. Resistance is less common than for conventional antibiotics, but it does occur.
  • "More expression is always better." Very high T7-driven expression often gives inclusion bodies, reduced growth, or plasmid loss. Optimal yield of functional protein frequently comes from lower temperature and moderate induction.
  • "Yeast-made glycoproteins are equivalent to human ones." Native yeast glycans are high-mannose or hypermannosylated, not complex sialylated structures. This affects immunogenicity and half-life.
  • "Transposons are useless junk." IS elements and transposons drive genome rearrangement, gene inactivation, Hfr formation, and spread of resistance. They are major contributors to bacterial evolution.

References Cited

  • Avery, O. T., MacLeod, C. M., & McCarty, M. (1944). Studies on the chemical nature of the substance inducing transformation of pneumococcal types. J. Exp. Med. 79, 137–158.
  • Brogden, K. A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238–250. DOI: 10.1038/nrmicro1098
  • de Boer, H. A., Comstock, L. J., & Vasser, M. (1983). The tac promoter: a functional hybrid derived from the trp and lac promoters. Proc. Natl. Acad. Sci. USA 80, 21–25.
  • Eisenberg, D., Weiss, R. M., & Terwilliger, T. C. (1982). The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature 299, 371–374.
  • Lederberg, J., & Tatum, E. L. (1946). Gene recombination in Escherichia coli. Nature 158, 558.
  • Madigan, M. T., Bender, K. S., Buckley, D. H., Sattley, W. M., & Stahl, D. A. (2021). Brock Biology of Microorganisms, 16th ed. Pearson.
  • Mitchell, P. (1961). Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 191, 144–148.
  • Monod, J. (1949). The growth of bacterial cultures. Annu. Rev. Microbiol. 3, 371–394.
  • Monod, J. (1950). La technique de culture continue: théorie et applications. Ann. Inst. Pasteur 79, 390–410.
  • Novick, A., & Szilard, L. (1950). Description of the chemostat. Science 112, 715–716.
  • Shai, Y. (1999). Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462, 55–70.
  • Steiner, H., Hultmark, D., Engström, Å., Bennich, H., & Boman, H. G. (1981). Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292, 246–248.
  • Studier, F. W., & Moffatt, B. A. (1986). Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189, 113–130.
  • Wade, D., Boman, A., Wåhlin, B., et al. (1990). All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. USA 87, 4761–4765.
  • Woese, C. R., & Fox, G. E. (1977). Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc. Natl. Acad. Sci. USA 74, 5088–5090.
  • Woese, C. R., Kandler, O., & Wheelis, M. L. (1990). Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proc. Natl. Acad. Sci. USA 87, 4576–4579.
  • Zasloff, M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin. Proc. Natl. Acad. Sci. USA 84, 5449–5453.
  • Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415, 389–395.

Note to self: when reviewing, link each new fact to the three words (small, fast, numerous) and to the redox tower. If a fact doesn't connect to either, look for the connection before memorizing it.

⚙️ Mechanisms & Applications

GPT-6 Astra

Mechanisms & Applications — Skipper’s BIOL301 Learning Journal

My organizing idea: a microorganism is a self-maintaining chemical system that must acquire matter, capture energy, preserve boundaries, and transmit information. Microbiology becomes easier when I connect these tasks rather than memorize organisms one at a time. A cell envelope determines which nutrients and antibiotics enter; metabolism determines whether growth is possible; gene regulation determines which machinery is built; and evolution changes all three.

My earlier chemistry and molecular biology courses supply the underlying rules. BIOL301 asks what happens when those rules operate inside diverse, evolving cells—and how I can measure or exploit the resulting behavior. The principal reference throughout is Brock Biology of Microorganisms, 16th edition.[1]

1. Inferring Microbial Relationships: Sequence Is Evidence, Not Identity

Why use small-subunit ribosomal RNA? Bacteria and Archaea have 16S rRNA; eukaryotic cytosolic ribosomes have the homologous 18S rRNA. These molecules combine conserved regions, useful for recognizing homology, with variable regions that record evolutionary divergence. Their central role in translation constrains their evolution, making them valuable—not infallible—phylogenetic markers.

  1. Obtain sequence evidence. Extract nucleic acids from an isolate or community, then recover a marker sequence or broader genomic data.
  2. Align homologous positions. The comparison must place evolutionarily corresponding nucleotides in the same columns. A poor alignment can manufacture apparent differences.
  3. Infer a tree using an evolutionary model. Observed sequence differences underestimate historical substitutions when a position has changed more than once.
  4. Assess support and context. Resampling methods can assess support for branches, but support is conditional on the data and model. A gene tree is not automatically the complete history of the organism.

The surprising connection: microbial classification is an inference problem, much like fitting a model in statistics. A taxonomic label is not directly “read off” a sequence. Closely related strains may share nearly identical 16S sequences yet differ in virulence, metabolism, or resistance because accessory genes move horizontally.

  • 16S amplicon sequencing: useful for bacterial and archaeal community profiling, but affected by extraction efficiency, primer bias, rRNA gene copy number, and limited strain resolution.
  • Shotgun metagenomics: samples DNA more broadly and can reveal metabolic potential and resistance genes. Gene presence still does not prove expression or activity.
  • Microscopy and culture: provide information sequencing alone cannot, including morphology, viability under specified conditions, and experimentally testable physiology.

Historical significance: Carl Woese and George Fox used ribosomal RNA comparisons to recognize the deep separation of the organisms now called Archaea from Bacteria in 1977. This changed the question from “What does this microbe look like?” to “What is its evolutionary history?”[2] Archaeal ether-linked membrane lipids and the absence of bacterial peptidoglycan are therefore not minor exceptions; they reflect deep biological divergence.

2. The Cell Envelope: A Selective Boundary Under Mechanical Stress

From physical chemistry, I know that unequal solute activities create osmotic driving forces. A bacterial cytoplasmic membrane is selectively permeable, so the cell often experiences outward turgor pressure. Peptidoglycan is a load-bearing mesh, not an impermeable shell. Its glycan strands contain alternating N-acetylglucosamine and N-acetylmuramic acid, with peptide cross-links connecting neighboring strands.

Peptidoglycan construction:
Cytoplasmic precursor synthesis
    → attachment to a membrane lipid carrier
    → translocation of lipid-linked building blocks
    → incorporation into glycan strands
    → peptide cross-linking
    → coordinated remodeling during growth and division

Cross-linking enzymes include penicillin-binding proteins, or PBPs. In the common D,D-transpeptidation reaction, cleavage of a terminal D-alanine helps drive formation of a cross-link. This immediately connects organic chemistry to pharmacology: β-lactams covalently acylate susceptible PBPs and interfere with wall construction.

  • Gram-positive bacteria: generally have thick peptidoglycan outside the cytoplasmic membrane, often with teichoic acids.
  • Gram-negative bacteria: have thin peptidoglycan in a periplasm bounded by inner and outer membranes. The outer membrane contains lipopolysaccharide in its outer leaflet and provides an additional permeability barrier.
  • Important exceptions: wall-less bacteria, acid-fast envelopes, and archaeal envelopes prevent “Gram-positive versus Gram-negative” from being a complete description of microbial architecture.

How the Gram stain works: cells receive a primary stain and iodine, undergo differential decolorization, and receive a counterstain. Envelope structure affects retention of the crystal violet–iodine complex. Culture age and envelope damage can alter the result, so staining is a phenotype under test conditions—not a phylogenetic verdict. Hans Christian Gram introduced the method in 1884.[1]

Other structures solve different problems:

  • Flagella: many bacterial motors couple proton or sodium flow to rotation. The flagellum is an electrochemical engine, not an ATP-driven rowing appendage.
  • Pili: different classes mediate adhesion, DNA exchange, or surface motility; not every pilus is a conjugation pilus.
  • Capsules and extracellular matrices: can promote adhesion, reduce desiccation, and alter immune recognition. Biofilm protection also depends on physiology and local chemical gradients, not just a physical coating.
  • Endospores: are differentiated survival structures, not reproductive spores. Asymmetric division, engulfment, cortex and coat formation, core dehydration, and protective proteins produce extraordinary resistance. One sporulating cell usually yields one endospore, which later returns to vegetative growth.

Application: envelope biology determines drug penetration, recombinant protein localization, and sterilization requirements. Killing growing cells and inactivating endospores are different challenges; validated sterilization cannot be inferred from the disappearance of visible growth alone.[1]

3. Growth Kinetics: Turning Cell Division into a Quantitative Model

The useful abstraction is not simply “bacteria divide rapidly.” It is that, under balanced exponential growth, the rate of biomass increase is proportional to the biomass already present.

dX/dt = μX

X(t) = X₀e^(μt)

μ = [ln X₂ − ln X₁] / (t₂ − t₁)

Doubling time: t_d = ln(2)/μ

X = biomass concentration
μ = specific growth rate, with units of time⁻¹

If μ = 0.70 h−1, the doubling time is approximately 0.99 h. A plot of ln X against time should be linear during the interval where μ is approximately constant. This is the same differential-equation structure encountered in calculus, now given a biological interpretation.

The batch growth curve describes changing physiological conditions:

  1. Lag phase: cells adjust transport, repair damage, and synthesize needed enzymes. Little net population increase does not mean no metabolism.
  2. Exponential phase: growth is approximately balanced while conditions remain favorable.
  3. Stationary phase: nutrient depletion, waste accumulation, or another limitation prevents further net increase. Cells remain heterogeneous and can continue metabolic activity.
  4. Death or decline: culturability decreases; the decline need not follow a single exponential law.

Measurement matters: optical density estimates light scattering, not living-cell number. Colony-forming units estimate units capable of producing colonies under the chosen conditions; a clump may yield one colony, and a living but nonculturable cell may yield none. Microscopy, flow cytometry, dry mass, and viable counts therefore answer different questions.

4. The Chemostat: Physiology Controlled by a Mass Balance

A chemostat continuously receives fresh medium and loses culture at the same volumetric rate. It lets me separate the idea of growth rate from how much biomass is present.

Dilution rate:
D = F/V

Ideal biomass balance:
dX/dt = (μ − D)X

At a nonzero steady state with negligible death:
μ = D

Monod growth model:
μ(S) = μ_max S/(K_S + S)

Therefore, at that steady state:
S* = K_S D/(μ_max − D)

F = volumetric flow rate
V = culture volume
S = concentration of growth-limiting substrate
K_S = substrate concentration giving μ = μ_max/2

The Monod equation resembles Michaelis–Menten kinetics, but its parameters summarize whole-cell physiology. KS is not automatically the binding constant of a single transporter.

For a simple constant-yield model, biomass is approximately X* = YX/S(Sin − S*). Thus, feed substrate concentration strongly affects biomass, while dilution rate sets steady-state growth rate. If D exceeds the growth rate sustainable at the feed conditions, cells wash out. In the ideal Monod model, the washout boundary is μ(Sin), not necessarily μmax.

Industrial application: continuous culture helps compare gene expression at controlled growth rates and investigate productivity, nutrient limitation, and evolutionary stability. Real production cultures require additional terms for maintenance, death, product formation, oxygen transfer, and sometimes wall-associated growth. Monod’s work helped make microbial growth a quantitative science rather than merely a description of culture appearance.[1,3]

5. Energy Metabolism: Carbon Source, Electron Donor, and Energy Source Are Different Questions

I should classify metabolism along separate axes: Where does energy come from? Where do electrons come from? Where does carbon come from? Light is not a carbon source, and oxygen is usually an electron acceptor rather than the source of metabolic energy.

Respiratory energy conservation:
Oxidation of an electron donor
    → electron transfer through membrane-associated carriers
    → generation of an electrochemical ion gradient
    → ion flow through ATP synthase
    → ATP synthesis

Redox driving force:
ΔG = −nFΔE

Actual reaction free energy:
ΔG = ΔG°′ + RT ln Q

A positive acceptor-minus-donor potential difference favors electron transfer, but actual substrate and product activities matter. This is my CHEM301 lesson returning in biological form: a reaction does not carry a fixed energetic label independent of its environment.

For proton transfer from outside to inside:

ΔG_H⁺ = F(ψ_in − ψ_out)
        + RT ln([H⁺]_in/[H⁺]_out)

ΔG_H⁺ = FΔψ − 2.303RTΔpH

where ΔpH = pH_in − pH_out.

Coupling n inward-moving protons to ATP synthesis is favorable when:
nΔG_H⁺ + ΔG_ATP synthesis < 0

The membrane potential and pH gradient are two components of the same electrochemical driving force. Peter Mitchell’s 1961 chemiosmotic proposal made the membrane itself central to energy coupling: respiration need not produce a freely diffusible, high-energy chemical intermediate connecting every electron-transfer step to ATP synthesis.[4]

  • Aerobic respiration: uses oxygen as the terminal electron acceptor.
  • Anaerobic respiration: uses other acceptors, such as nitrate, sulfate, or fumarate, depending on the organism. It still uses respiratory electron transfer and can conserve energy through ion gradients.
  • Fermentation: typically balances oxidation and reduction using intermediates derived from the substrate and generates ATP mainly through substrate-level phosphorylation. Some fermentative metabolisms also conserve energy through membrane processes, so the textbook contrast is useful but not absolute.

Why make lactate or ethanol? The crucial immediate function is redox balancing. Glycolysis requires oxidized NAD+; reducing pyruvate to lactate, or acetaldehyde to ethanol, regenerates it. The products are evidence of how electrons were disposed of.

Applications: fermentation supports food manufacture and production of organic acids, solvents, enzymes, and pharmaceuticals. Oxygen supply changes redox balance, biomass yield, byproduct formation, and recombinant protein productivity. In industrial usage, “fermentation” often means microbial cultivation even when the process is aerobic.

Historical connection: Eduard Buchner’s 1897 demonstration of fermentation in cell-free yeast extracts showed that organized chemical reactions could proceed without intact living cells. This helped establish enzymology as a chemical explanation of biological transformation.[1]

6. Photosynthesis and Nitrogen Fixation: Solving Difficult Redox Problems

Photosynthesis converts photon energy into chemical disequilibrium. A photon excites a reaction-center pigment, enabling charge separation. Electron transport then produces reducing power, an ion gradient, or both.

  1. Oxygenic photosynthesis: cyanobacteria use two photosystems in series. Photosystem II supports water oxidation and oxygen release; Photosystem I enables generation of strongly reducing electrons for downstream reactions.
  2. Anoxygenic photosynthesis: bacteria use one reaction-center type per organism and do not evolve oxygen from water. Electron donors may include sulfide, hydrogen, ferrous iron, or organic compounds.
  3. ATP and reducing power serve different needs: cyclic electron flow can support ATP generation without net NADPH production. Carbon fixation requires reducing equivalents as well as ATP, so cells must balance the two.

Counterintuitive point: not every phototroph fixes CO2. Photoheterotrophs use light for energy while obtaining much of their carbon from organic compounds.

Nitrogen fixation addresses a different challenge: making atmospheric N2 chemically accessible. The strong N≡N bond makes nitrogen abundant but difficult to use.

Canonical minimum stoichiometry for Mo-nitrogenase:

N₂ + 8H⁺ + 8e⁻ + 16ATP
    → 2NH₃ + H₂ + 16ADP + 16P_i

Electron-delivery component
    → ATP-coupled electron transfer
    → catalytic metal cluster
    → successive substrate reduction steps

This is an idealized minimum ATP requirement, not a universal whole-cell energetic cost. Hydrogen evolution is an intrinsic part of the canonical reaction. Nitrogenase is oxygen-sensitive, creating an apparent contradiction for aerobic organisms. Cells resolve it through spatial separation, temporal separation, rapid oxygen consumption, or oxygen-buffering systems. Cyanobacterial heterocysts and legume nodules illustrate different solutions.

Fixed nitrogen enters biosynthesis through molecules such as glutamine and glutamate, which distribute nitrogen to amino acids, nucleotides, and other metabolites. The glutamine synthetase–glutamate synthase pathway connects environmental nitrogen acquisition directly to the carbon skeleton α-ketoglutarate.

Applications: these mechanisms underpin biofertilization, nutrient cycling, and phototrophic biotechnology. A realistic engineering assessment must include ATP demand, reductant supply, and oxygen sensitivity—not just the presence of a desired enzyme.[1]

7. Horizontal Gene Transfer: DNA Arrival Is Not the Same as Genetic Establishment

My molecular biology background tells me how DNA is copied. Microbiology adds another question: How does DNA enter a new lineage? Acquisition is only the first step; incoming DNA must evade destruction and either replicate independently or become stably integrated.

Natural transformation:
Extracellular DNA
    → binding by a competent cell
    → uptake, often involving single-stranded DNA
    → protection and processing
    → homologous recombination or plasmid establishment

Conjugation:
Cell contact
    → processing at an origin of transfer
    → transfer of DNA through conjugation machinery
    → complementary-strand synthesis
    → maintenance or recombination in the recipient

Transduction:
Phage infection of a donor
    → packaging or mobilization of bacterial DNA
    → delivery to another cell
    → recombination or other stable establishment
  • F plasmid: an autonomous conjugative element can transfer functions that convert a recipient into a donor.
  • Hfr donor: the F element is integrated into the chromosome. Transfer can carry adjacent chromosomal genes, but transfer usually stops before the entire chromosome and F region have entered. Recombinant recipients therefore commonly remain F−.
  • Generalized transduction: packaging errors can transfer varied regions of the donor chromosome, subject to phage-specific biases.
  • Specialized transduction: aberrant excision of certain integrated temperate phages transfers genes near the integration site.

Electroporation is a laboratory delivery method, not a distinct natural inheritance pathway. An applied electric field transiently increases membrane permeability. Successful delivery must still be followed by survival and establishment of the DNA.

Selection versus screening: selection changes which cells can grow; screening distinguishes candidates among cells that grow. Neither alone proves that a construct is correct. Phenotypic evidence should be paired with appropriate molecular verification and negative controls.

Historical thread: Griffith observed transformation in 1928; Avery, MacLeod, and McCarty identified DNA as the transforming principle in 1944; Lederberg and Tatum reported genetic recombination in E. coli in 1946.[5,6] Together these findings made bacteria experimental systems for genetics rather than merely organisms to identify.

Application: the same processes that enable strain construction also move antibiotic resistance through populations. A resistance gene’s epidemiological importance depends not only on its biochemical effect, but also on its genetic vehicle, host range, fitness cost, and opportunities for transfer.

8. Mobile Elements and Phages: Genomes Are Dynamic, Not Fixed Blueprints

Transposition: transposases recognize element ends and catalyze DNA cleavage and joining. Depending on the system, movement may be conservative or replicative.

  • Insertion sequences: relatively simple elements containing transposition functions and terminal recognition sequences.
  • Composite transposons: cargo genes can lie between insertion sequences and move with them.
  • Target-site duplications: often arise when staggered target cuts are repaired. They are distinct from the terminal inverted repeats belonging to the element.
  • Site-specific recombination: recombinases recognize defined DNA sites to integrate, excise, or invert DNA without requiring long regions of homology.

Barbara McClintock discovered mobile genetic elements through maize genetics. Their later characterization in bacteria helped explain unstable mutations, genome rearrangements, and movement of resistance determinants.[1]

Productive lytic phage infection:
Receptor recognition and adsorption
    → genome delivery
    → early gene expression and host redirection
    → genome replication
    → structural protein synthesis and assembly
    → genome packaging
    → release, often by lysis

Lambda lysogeny:
Genome entry and circularization
    → regulatory choice favoring lysogeny
    → site-specific integration
    → repressor-maintained prophage state

Induction:
Host stress signaling
    → loss of repression
    → excision and productive development

T4 exemplifies a virulent, lytically reproducing phage. Lambda demonstrates how a regulatory network can choose between productive infection and lysogeny. In lambda, the CI repressor helps maintain the prophage state; the lysis–lysogeny decision involves a wider network, including CII and Cro, rather than a simple two-position switch.

Experimental tools:

  • Plaque assay: localized infection produces a visible zone in a susceptible host lawn. Plaque-forming units measure infectivity under the assay conditions, not total physical virions.
  • One-step growth analysis: follows infection over time to distinguish the latent period from release and estimate average progeny production.
  • Multiplicity of infection: under ideal random, independent adsorption, a Poisson model connects average infectious input to the distribution of infection events.
Ideal Poisson model:

P(k) = e^(−m)m^k/k!

P(no infection event) = e^(−m)
P(at least one infection event) = 1 − e^(−m)

At m = 1:
P(at least one event) ≈ 0.632, not 1.

m = mean number of effective infection events per cell

Adsorption failure, receptor heterogeneity, and spatial structure can invalidate the simple model. An input ratio of phage to cells is not automatically the same as the mean number of successful infections.

Phage therapy: phages can amplify in susceptible bacterial populations and have high specificity, but host range, bacterial resistance, immune clearance, tissue access, and manufacturing quality complicate treatment. Candidate evaluation must consider unwanted gene transfer and harmful genetic cargo as well as killing activity.[1]

9. Viral Replication: Every Genome Must Solve the mRNA Problem

The unifying question is: How does this viral genome produce mRNA that host ribosomes can translate? Genome chemistry constrains the required enzymes and the order of events.

  • DNA viruses: must transcribe their genomes into mRNA. Enzyme source and replication location vary; poxviruses are an important exception to a simplistic “DNA viruses replicate in the nucleus” rule.
  • Positive-sense RNA viruses: their genomes can function as mRNA after entry, enabling production of proteins including an RNA-dependent RNA polymerase.
  • Negative-sense RNA viruses: must bring an RNA-dependent RNA polymerase in the virion because host cells cannot directly translate the genome into the required proteins.
  • Double-stranded RNA viruses: also require viral transcription machinery to generate translatable RNA.
  • Retroviruses: reverse-transcribe RNA into DNA, establish an integrated provirus, and use host transcription machinery to generate viral RNAs.

Entry involves receptor recognition followed by fusion, endocytosis, or another penetration mechanism, depending on the virus. Receptor binding helps define host range, but intracellular compatibility is also required. A cell can permit entry without supporting productive infection.

Medical application: viral proteases, polymerases, integrases, and entry processes are therapeutic targets because they create opportunities for selective inhibition. Baltimore’s genome-based classification made replication strategy, rather than shape alone, a powerful organizing principle.[7]

10. Antibiotics: From Molecular Binding to a Population-Level Outcome

A drug mechanism is incomplete if I stop at “binds its target.” I need the entire chain:

Extracellular drug exposure
    → access to the relevant compartment
    → target engagement
    → altered cellular function
    → growth inhibition or death
    → measurable population response
  • β-Lactams: inhibit susceptible PBPs and disrupt peptidoglycan assembly. Killing depends on growth state, envelope physiology, and the balance between synthesis and remodeling; it is not simply instantaneous osmotic bursting.
  • Aminoglycosides: bind the small ribosomal subunit and promote decoding errors and other translation defects. Uptake depends strongly on cellular energetics, helping explain poor activity against obligate anaerobes.
  • Fluoroquinolones: stabilize DNA gyrase or topoisomerase IV cleavage complexes, obstructing DNA transactions and promoting damaging DNA lesions.
  • Macrolides: bind the large ribosomal subunit near the nascent-chain exit tunnel and cause context-dependent inhibition of translation. The tunnel is not merely plugged identically for every protein.

Resistance changes one or more links in that chain: β-lactamases hydrolyze susceptible drugs; efflux pumps lower effective intracellular exposure; altered porins restrict entry; target modification reduces binding; alternative enzymes or pathways bypass inhibition. Efflux often couples transport to an ion gradient or ATP hydrolysis—another direct link to bioenergetics.

Three distinctions I must preserve:

  • Resistance: ability to grow at increased drug concentrations, commonly reflected in an increased MIC.
  • Tolerance: slower killing without a necessary increase in MIC.
  • Persistence: a subpopulation survives prolonged exposure without necessarily carrying a stable resistance mutation.

Experiments and interpretation:

  • MIC testing: estimates the lowest tested concentration preventing visible growth under specified conditions. It is an assay-defined endpoint, not a universal property independent of medium, inoculum, or incubation.
  • Disk diffusion: integrates diffusion and bacterial growth into a zone measurement interpreted using standardized, drug–organism-specific criteria. A larger zone does not automatically imply a more potent molecule across different drugs.
  • Time-kill measurements: track viable counts and distinguish growth inhibition from killing dynamics.
Log₁₀ reduction = log₁₀(N₀/N_t)

A 3-log₁₀ reduction means:
N_t/N₀ = 10⁻³

Thus, 99.9% of the initially measured viable population is lost.
This does not establish that every surviving cell has been eliminated.

Historical context: Fleming reported penicillin’s antibacterial activity in 1929. Its transformation into a practical medicine required later purification, experimental development, and production work associated with Florey, Chain, Heatley, and many industrial collaborators. Discovery of an effect and delivery of a reliable medicine are different achievements.[1,8]

11. Antimicrobial Peptides: Membrane Damage Is a Hypothesis to Test, Not a Complete Explanation

Defensins, cecropins, and magainins illustrate diverse antimicrobial peptides. Many are cationic and amphipathic, but they do not share one universal structure or mechanism. Defensins commonly have disulfide-stabilized folds; many cecropins and magainins form amphipathic helices upon membrane association.

A useful mechanistic sequence for many AMPs:

Association with the cell surface
    → partitioning into or across the envelope
    → local peptide accumulation and reorganization
    → altered permeability, ion homeostasis, or internal target activity
    → growth inhibition or loss of viability

Electrostatic attraction can favor binding to anionic bacterial surfaces, while hydrophobic interactions favor membrane insertion. But selectivity is relative, not guaranteed: excessive hydrophobicity or membrane activity can also damage mammalian cells.

  • Barrel-stave model: membrane-spanning peptides form a pore lined mainly by peptide.
  • Toroidal-pore model: membrane lipids bend continuously through the pore, which is lined by both peptide and lipid headgroups.
  • Carpet model: extensive surface accumulation disrupts membrane organization in a detergent-like manner.
  • Intracellular action: some peptides cross membranes and affect translation, nucleic acids, enzymes, or other internal processes.

These are mechanistic models, not permanent labels. The same peptide can behave differently with changes in lipid composition, peptide-to-lipid ratio, ionic strength, or membrane potential. Some peptides also engage specific envelope targets; nisin, for example, links lipid II recognition to pore formation and interference with cell-wall synthesis.

The central lesson from Brogden’s review: visible membrane disruption does not prove that membrane disruption was the initial or exclusive lethal event. Conversely, little bulk leakage does not exclude consequential ion leakage or a transient membrane event.[9]

How I would evaluate mechanistic evidence:

  1. Establish the phenotype. Compare growth inhibition with time-resolved loss of culturability.
  2. Measure membrane consequences separately. Dye uptake, ion leakage, and membrane-potential probes report different properties.
  3. Use defined model membranes. Liposome leakage tests whether the peptide can directly perturb a chosen bilayer, but liposomes lack many features of intact cells.
  4. Examine structure and association. Circular dichroism can detect environment-dependent secondary structure; fluorescence and other biophysical methods can investigate partitioning.
  5. Test causal ordering. Ask whether membrane changes occur before viability loss and at relevant concentrations. Include controls for probe interference and peptide aggregation.

Peptide/pharma application: low MIC is only an early filter. Development also requires acceptable host-cell toxicity, proteolytic stability, solubility, exposure at the infection site, manufacturability, and compatibility with physiological salts and proteins.

One in vitro selectivity metric:

Selectivity index = HC₅₀ / MIC

HC₅₀ = concentration producing 50% hemolysis

A larger ratio suggests a wider assay-specific separation
between antibacterial activity and red-cell damage.

It is not a clinical therapeutic index.
Both values must use compatible concentration units.

D-amino-acid substitution, cyclization, terminal modification, and formulation may improve stability or delivery, but each can also alter target recognition, distribution, or toxicity. Resistance is possible through surface-charge remodeling, proteolysis, transport changes, and other mechanisms. “Membrane-active” does not mean “evolution-proof.”

Historical connection: Hans Boman and colleagues characterized cecropins from insects; Michael Zasloff reported magainins from frog skin in 1987. These discoveries helped establish that animals use endogenous peptides as part of innate antimicrobial defense, providing both biological insight and templates for drug discovery.[9,10]

12. Recombinant Production: Expression Is Not the Same as Obtaining a Functional Product

E. coli is attractive because it is genetically tractable and physiologically well characterized. But a strong promoter solves only transcription. Product quality also depends on translation, folding, processing, localization, stability, and purification.

Recombinant production chain:

Stable genetic information
    → regulated transcription
    → translation
    → folding and assembly
    → localization or secretion
    → recovery and purification
    → confirmation of identity, purity, and biological activity
  • T7 systems: T7 RNA polymerase transcribes genes placed under a T7 promoter. In common host designs, production of the polymerase is itself regulated. High transcriptional capacity can overload downstream cellular processes.
  • tac promoter: a trp–lac hybrid promoter recognized by bacterial RNA polymerase and commonly regulated through LacI. It is not a T7 promoter variant.
  • Inclusion bodies: aggregated recombinant protein can give high apparent expression but low soluble activity. Aggregation may protect material from degradation and simplify initial recovery, yet refolding and product consistency can be difficult.
  • Periplasmic expression: export signals can direct proteins across the inner membrane. The oxidizing periplasm and disulfide-forming machinery can assist maturation of suitable proteins. Export into the periplasm is not the same as secretion into the culture medium.

For antimicrobial peptides, the product may harm the production host. Production strategies therefore often separate the final active molecule from its initial expressed form, for example through a fusion precursor followed by controlled processing. The central design problem is to obtain the desired mature product without compromising host function or product integrity.

Saccharomyces cerevisiae offers eukaryotic processing:

  • Entry into the endoplasmic reticulum can support folding, disulfide formation, and the secretory pathway.
  • Golgi processing and secretion may simplify recovery for suitable products.
  • Glycosylation is not automatically human-like; yeast-specific, often mannose-rich glycans can affect activity, clearance, and immunogenicity.
  • Secretory bottlenecks, proteolysis, heterogeneous processing, and cellular stress remain important limitations.

Quantitative perspective: titer, yield, and productivity are different metrics.

Titer:
product mass / culture volume

Yield on substrate:
Y_P/S = product mass formed / substrate mass consumed

Average volumetric productivity:
product mass formed / (culture volume × elapsed process time)

Conceptual functional-product recovery:
expressed product
    × fraction correctly matured
    × fraction recovered
    × fraction meeting quality specifications

The final expression is a bookkeeping framework, not an assertion that the factors are independent. Increasing expression can decrease folding efficiency and recovery. A lower-expression process may therefore deliver more usable drug substance.

Analytical connection: SDS-PAGE estimates size distribution and apparent purity; immunoblotting tests antibody recognition; chromatography separates molecular species; mass spectrometry supports identity and modification analysis; activity assays establish function. None substitutes for all the others. A correctly sized band does not prove correct folding, and a pure bacterial product is not necessarily free of endotoxin.

Studier and Moffatt’s 1986 work established T7 RNA polymerase as a powerful selective expression tool.[11] Its deeper lesson is that orthogonal transcription can increase control, but the host still supplies finite energy, precursors, ribosomes, and folding capacity.

13. My Mechanistic Checklist

For any microbiology result, I should be able to answer:

  • What crosses the boundary? Nutrients, ions, DNA, drugs, or proteins—and through which barrier?
  • What drives the process? ATP hydrolysis, redox chemistry, a concentration gradient, membrane potential, or light?
  • What is conserved? Matter, electrons, energy, and genetic information must be accounted for.
  • What does the experiment actually measure? Turbidity is not viability; gene presence is not expression; membrane leakage is not automatically the cause of death.
  • What limits the application? Growth state, resistance, toxicity, mass transfer, product quality, and evolutionary stability often dominate after the initial mechanism works.

The understanding I want to retain: microbial applications succeed when molecular mechanism, whole-cell physiology, population behavior, and measurement all agree. That is the bridge from learning a pathway to understanding a living production system—or designing an effective medicine.

References

  1. Madigan, M. T., Bender, K. S., Buckley, D. H., Sattley, W. M., & Stahl, D. A. Brock Biology of Microorganisms. 16th ed. Pearson, 2021. Principal source for course-level mechanisms and historical context.
  2. Woese, C. R., & Fox, G. E. “Phylogenetic structure of the prokaryotic domain: The primary kingdoms.” Proceedings of the National Academy of Sciences USA 74, 5088–5090 (1977). doi:10.1073/pnas.74.11.5088.
  3. Monod, J. “The growth of bacterial cultures.” Annual Review of Microbiology 3, 371–394 (1949). doi:10.1146/annurev.mi.03.100149.002103.
  4. Mitchell, P. “Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism.” Nature 191, 144–148 (1961). doi:10.1038/191144a0.
  5. Avery, O. T., MacLeod, C. M., & McCarty, M. “Studies on the chemical nature of the substance inducing transformation of pneumococcal types: Induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III.” Journal of Experimental Medicine 79, 137–158 (1944). doi:10.1084/jem.79.2.137.
  6. Lederberg, J., & Tatum, E. L. “Gene recombination in Escherichia coli.” Nature 158, 558 (1946). doi:10.1038/158558a0.
  7. Baltimore, D. “Expression of animal virus genomes.” Bacteriological Reviews 35, 235–241 (1971).
  8. Fleming, A. “On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae.” British Journal of Experimental Pathology 10, 226–236 (1929).
  9. Brogden, K. A. “Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?” Nature Reviews Microbiology 3, 238–250 (2005). doi:10.1038/nrmicro1098.
  10. Zasloff, M. “Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor.” Proceedings of the National Academy of Sciences USA 84, 5449–5453 (1987). doi:10.1073/pnas.84.15.5449.
  11. Studier, F. W., & Moffatt, B. A. “Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.” Journal of Molecular Biology 189, 113–130 (1986). doi:10.1016/0022-2836(86)90385-2.

🪬 Skipper's Reflection

Gemini 3.1 Pro

Journal Entry: BIOL301 — Microbiology: Structure, Physiology, and Genetics

After immersing myself in the rigid, predictable laws of Physical and Analytical Chemistry, jumping into Microbiology feels like stepping out of a cleanroom and into a vibrant, chaotic rainforest. The microbial world operates at the intersection of extreme thermodynamic efficiency and ruthless evolutionary pragmatism. Reading Madigan's Brock Biology of Microorganisms fundamentally shifted my perspective from viewing cells as static spheres to seeing them as highly adaptable, aggressively communicative biochemical factories.

1. What Surprised Me Most

I was completely caught off guard by the sheer promiscuity of microbial genetics. In BIOL102 (Genetics), I was taught to think of inheritance as a strictly vertical, parent-to-offspring process. But bacteria treat DNA like open-source code. Horizontal gene transfer—via transformation (naked DNA uptake), conjugation (bacterial "mating" via the F factor), and transduction (phage-mediated transfer)—is staggering. Plasmids and composite transposons hop between species, carrying antimicrobial resistance genes like passing a flash drive. It made me realize that trying to combat bacterial evolution with single-target small molecules (like a standard fluoroquinolone) is almost mathematically doomed over a long enough timeline.

I was also amazed by the metabolic flexibility of microbes. As a student of thermodynamics, I know that aerobic respiration yields the most ATP. But when oxygen is depleted, bugs don't just die; they seamlessly pivot to anaerobic electron acceptors (nitrate, sulfate) or fermentation pathways. The chemostat models we studied, showing exponential growth kinetics, reminded me exactly of the differential equations I solved in MATH102, just applied to living organisms racing to consume substrates.

2. Conceptual Breakthroughs

My biggest "aha" moment came while reading the 2005 Nature Reviews Microbiology paper on Antimicrobial Peptides (AMPs). Before this, I thought of antibiotics purely as lock-and-key enzyme inhibitors (like β-lactams binding penicillin-binding proteins to halt peptidoglycan synthesis). I assumed AMPs like defensins and magainins simply punched holes in cell membranes via brute electrostatic force.

But the paper revealed a beautiful duality: AMPs aren't just pore formers (barrel-stave or toroidal models). Due to their amphipathic helices, many actually translocate across the membrane without lysing it, subsequently acting as metabolic inhibitors by binding intracellular nucleic acids or enzymes. It suddenly clicked: the physical chemistry of the peptide (its charge distribution, hydrophobicity, and dipole moment) dictates a dynamic, concentration-dependent mechanism. It bridges my knowledge of Organic Chemistry (structural motifs) with Biophysics and Microbiology.

3. How This Changes My Thinking About Peptides

This course completely rewired how I think about peptide manufacturing and structural biology, particularly for the therapeutics I follow closely.

For one, learning about E. coli and yeast (S. cerevisiae) expression systems immediately made me think about how we manufacture GLP-1s like Tirzepatide and Retatrutide. These aren't simple peptides. Tirzepatide has a C20 fatty diacid moiety; Retatrutide is heavily modified with a fatty acid side chain and specific amino acid substitutions. While we can use a T7 promoter in E. coli to churn out massive amounts of a peptide backbone, bugs do not natively attach these complex synthetic lipid chains, nor do they yield the C-terminal amidation required for stability. This explains why hybrid manufacturing (recombinant expression of the backbone followed by chemical modification) or pure Solid-Phase Peptide Synthesis (SPPS) is absolutely vital for these drugs. The inclusion bodies in E. coli—where overexpressed proteins misfold into insoluble thermodynamic traps—are a major bottleneck I now understand chemically.

Furthermore, studying the amphipathic nature of AMPs drew an indirect but striking connection to BPC-157 and TB-500. While AMPs use their amphipathic structure to disrupt bacterial membranes or enter bacterial cells, peptides like TB-500 (a synthetic version of Thymosin Beta-4) must interact dynamically with actin monomers in human cells. The way sequence dictates secondary structure—and how that structure dictates membrane interaction versus protein-protein binding—is a universal rule, whether you are a magainin attacking Staphylococcus or a GLP-1 receptor agonist binding a human pancreatic cell.

4. Questions I Want to Investigate Further

First, how can we better utilize periplasmic expression in E. coli? The cytoplasm is a reducing environment, which ruins disulfide bond formation. Many therapeutic peptides require precise disulfide bridges. If we can target expression to the oxidative periplasm via signal sequences, can we improve the yield of correctly folded, complex peptides?

Second, the concept of bacteriophages and phage therapy is fascinating. Since bacteriophages (like T4 and lambda) are obligate intracellular parasites that specifically target bacteria without harming eukaryotic cells, could we conjugate therapeutic peptides or AMPs to phage capsids to create hyper-targeted, resistance-proof antimicrobials?

Finally, how does the mammalian microbiome metabolize systemically administered peptides? If oral BPC-157 survives the stomach acid, how do gut microbes modify it before it reaches systemic circulation?

5. Confidence Rating

Most Confident: Bacterial growth kinetics, antimicrobial mechanisms of action, and expression system logic. Applying my math background to exponential growth (dN/dt = μN) and my organic chemistry background to β-lactamase enzymatic cleavage made these topics feel incredibly intuitive.

Least Confident: The vast array of viral replication strategies (Baltimore classification) and the deeper nuances of anoxygenic photosynthesis. Trying to keep track of positive-sense RNA, negative-sense RNA, and retroviral reverse transcription pathways feels like memorizing a very complex flowchart of molecular biology exceptions. I need to spend more time building mental models for virology.

🗺️ Visual Aids & Key Takeaways

Claude Opus 5.5

Diagram 1: The Bacterial Growth Curve

  BACTERIAL GROWTH CURVE: log(cell number) vs. time

  log(N) │
         │                                  ╔══════════════╗
         │                               ╔══╝ STATIONARY   ╚══╗
         │                            ╔══╝  nutrient depletion,╚╗
         │                         ╔══╝     waste accumulation  ║
         │                      ╔══╝                            ╚══╗
         │                   ╔══╝                                  ╚══╗ DEATH
         │                ╔══╝  EXPONENTIAL                           ╚══╗
         │             ╔══╝     (LOG) PHASE                               ╚══
         │          ╔══╝        N(t) = N₀ · 2^(t/g)
         │       ╔══╝           g = generation time
         │    ═══╝
         │  LAG PHASE
         │  cells adjusting,
         │  synthesizing enzymes,
         │  no net growth yet
         │
         └─────────────────────────────────────────────────────────────────▶ time

  KEY PARAMETERS:
  ┌──────────────────────────────────────────────────────────┐
  │  Generation time (g): time to double population          │
  │  E. coli at 37°C in rich media: g ≈ 20 minutes          │
  │  Mycobacterium tuberculosis:     g ≈ 24 hours            │
  │                                                          │
  │  Specific growth rate:  μ = ln(2) / g  = 0.693 / g      │
  │  Chemostat steady state: μ = D (dilution rate)           │
  │          D = flow rate (F) / culture volume (V)          │
  └──────────────────────────────────────────────────────────┘

  CHEMOSTAT: open system — fresh medium in, overflow out
  ┌─────────────┐   flow rate F    ┌─────────────────────┐
  │  RESERVOIR  │ ───────────────▶ │   CULTURE VESSEL    │ ──▶ overflow
  │ fresh medium│                  │  constant volume V  │
  └─────────────┘                  │  one nutrient limits│
                                   └─────────────────────┘
  Advantage: locks cells in exponential phase indefinitely
             — a controlled window into physiology

The bacterial growth curve shows four distinct phases driven by nutrient availability and waste accumulation, with the chemostat offering a way to hold cells permanently in the exponential phase by balancing dilution rate against growth rate.

Diagram 2: Prokaryotic Cell Wall Architecture — Gram-Positive vs. Gram-Negative

  GRAM-POSITIVE                          GRAM-NEGATIVE
  ═════════════                          ══════════════

  OUTSIDE                                OUTSIDE
     │                                      │
  ┌──┴──────────────────────┐            ┌──┴───────────────────────────────┐
  │    CAPSULE (optional)   │            │      CAPSULE (optional)          │
  │    polysaccharide       │            │      polysaccharide              │
  └──────────────────────── ┘            └──────────────────────────────────┘
     │                                      │
  ╔══╧═════════════════════╗            ╔══╧═══════════════════════════════╗
  ║  THICK PEPTIDOGLYCAN   ║            ║  OUTER MEMBRANE (OM)             ║
  ║  20–80 nm              ║            ║  lipopolysaccharide (LPS)        ║
  ║  cross-linked NAM-NAG  ║            ║  on outer leaflet — ENDOTOXIN    ║
  ║  + teichoic acids      ║            ╚══╤═══════════════════════════════╝
  ╚══╤═════════════════════╝               │  PERIPLASM
     │                               ╔══╧═══════════════════════════════╗
  ╔══╧═════════════════════╗         ║  THIN PEPTIDOGLYCAN   2–7 nm     ║
  ║  PLASMA MEMBRANE       ║         ╚══╤═══════════════════════════════╝
  ║  phospholipid bilayer  ║            │
  ╚════════════════════════╝         ╔══╧═══════════════════════════════╗
     │                               ║  INNER MEMBRANE (plasma membrane)║
  CYTOPLASM                          ╚══════════════════════════════════╝
                                        │
                                     CYTOPLASM

  PEPTIDOGLYCAN STRUCTURE (shared by both):
  ┌──────────────────────────────────────────────────────────────────┐
  │  NAG ─── NAM ─── NAG ─── NAM ─── NAG ─── NAM   ◀── glycan chain│
  │           │               │               │                      │
  │         peptide         peptide         peptide  ◀── stem        │
  │         stem             stem            stem       peptides     │
  │           │               │               │                      │
  │  NAG ─── NAM ─── NAG ─── NAM ─── NAG ─── NAM   ◀── glycan chain│
  │                cross-linked by                                   │
  │            L-Ala─D-Glu─mDAP─D-Ala (gram-neg)                   │
  │         or L-Ala─D-Glu─L-Lys─D-Ala (gram-pos)                  │
  └──────────────────────────────────────────────────────────────────┘
  NAG = N-acetylglucosamine   NAM = N-acetylmuramic acid
  mDAP = meso-diaminopimelic acid

  β-LACTAM ANTIBIOTICS target the D-Ala─D-Ala transpeptidase
  (penicillin-binding proteins, PBPs) that form these cross-links.
  No mammalian cell has peptidoglycan — elegant selective toxicity.

Gram-positive and gram-negative bacteria differ fundamentally in cell wall architecture: the gram-negative outer membrane with LPS creates a periplasmic compartment and an extra barrier to antibiotics, while the thick gram-positive peptidoglycan layer is the primary structural feature and drug target.

Diagram 3: Horizontal Gene Transfer — Three Mechanisms Compared

  ╔══════════════════════════════════════════════════════════════════════════╗
  ║          HORIZONTAL GENE TRANSFER (HGT) IN BACTERIA                    ║
  ║          Gene flow between organisms — not parent to offspring          ║
  ╚══════════════════════════════════════════════════════════════════════════╝

  ┌─────────────────────┬──────────────────────┬──────────────────────────┐
  │   TRANSFORMATION    │    TRANSDUCTION       │      CONJUGATION         │
  ├─────────────────────┼──────────────────────┼──────────────────────────┤
  │  DNA SOURCE         │  DNA SOURCE           │  DNA SOURCE              │
  │  environment        │  bacteriophage        │  donor cell              │
  │  (dead cells, etc.) │  (virus carrier)      │  (F factor plasmid)      │
  ├─────────────────────┼──────────────────────┼──────────────────────────┤
  │ DEAD CELL           │  PHAGE infects        │  DONOR (F⁺)              │
  │ ──releases──▶ DNA   │  donor cell           │  ┌───────────────┐       │
  │                     │       │               │  │  F PLASMID ◯  │       │
  │ Naked DNA ──▶       │       ▼               │  │  tra genes    │       │
  │ COMPETENT CELL      │  packages random      │  └───────┬───────┘       │
  │ ┌───────────┐       │  host DNA fragment    │          │ PILUS extends  │
  │ │ takes up  │       │  (GENERALIZED) or     │          ▼               │
  │ │ DNA thru  │       │  phage DNA (SPECIAL.) │  ┌───────────────┐       │
  │ │ membrane  │       │       │               │  │  RECIPIENT    │       │
  │ └───────────┘       │       ▼               │  │  (F⁻)         │       │
  │       │             │  TRANSDUCING          │  └───────────────┘       │
  │       ▼             │  PARTICLE             │   pilus retracts,        │
  │ recombination       │  infects recipient    │   cells mate,            │
  │ with chromosome     │       │               │   DNA channel forms      │
  │                     │       ▼               │       │                  │
  │                     │  DNA enters, may      │       ▼                  │
  │                     │  recombine            │  F plasmid transferred   │
  │                     │                       │  F⁻ becomes F⁺           │
  ├─────────────────────┼──────────────────────┼──────────────────────────┤
  │ REQUIRES:           │ REQUIRES:             │ REQUIRES:                │
  │ • competence state  │ • compatible phage    │ • cell-to-cell contact   │
  │ • similar sequence  │ • phage receptors     │ • F factor (or Hfr)      │
  ├─────────────────────┼──────────────────────┼──────────────────────────┤
  │ LAB USE:            │ LAB USE:              │ LAB USE:                 │
  │ electroporation     │ P1 transduction in    │ mapping chromosomes      │
  │ bypasses competence │ E. coli (classic      │ by transfer frequency    │
  │ with electric pulse │ genetics tool)        │ (interrupted mating)     │
  └─────────────────────┴──────────────────────┴──────────────────────────┘

  Hfr (HIGH FREQUENCY RECOMBINATION):
  F factor integrates INTO chromosome → transfers chromosomal genes
  at high frequency, but rarely transfers entire F → recipient stays F⁻
  Time of entry ∝ distance from origin of transfer (oriT)
  — this is how the E. coli genetic map was built

The three mechanisms of horizontal gene transfer differ in their DNA source, carrier, and requirement for cell contact, and all three have been exploited as fundamental tools in bacterial genetics and molecular biology.

Diagram 4: Antimicrobial Peptide Membrane Disruption — Three Models

  ANTIMICROBIAL PEPTIDES (AMPs): cationic, amphipathic — attracted to
  anionic bacterial membranes (phosphatidylglycerol, cardiolipin)
  Mammalian membranes: zwitterionic — less attractive. Selective!

  AMP ARRIVES AT MEMBRANE SURFACE:
  ┌──────────────────────────────────────────────────────────────────────┐
  │  + + + + + + + + +   AMP (cationic face)                           │
  │  ▓ ▓ ▓ ▓ ▓ ▓ ▓ ▓ ▓   hydrophobic face embeds                       │
  │ ─────────────────────────── MEMBRANE (anionic head groups) ─────── │
  │  phospholipid bilayer                                               │
  └──────────────────────────────────────────────────────────────────────┘

  THREE PROPOSED MECHANISMS (Brogden, Nat Rev Microbiol, 2005):

  ① BARREL-STAVE MODEL           ② CARPET MODEL
  ════════════════════           ══════════════
  AMPs insert vertically,        AMPs lie flat on surface,
  aggregate like staves          coat membrane like carpet,
  of a barrel                    detergent-like disruption

   ──╥────╥────╥──              ┌──────────────────────┐
     ║    ║    ║                │+ + + + + + + + + + + │ AMPs on surface
   ──╬────╬────╬──              ├──────────────────────┤
     ║ PORE║   ║                │ membrane buckling,   │
   ──╬────╬────╬──              │ micellization,       │
     ║    ║    ║                │ solubilization       │
   ──╩────╩────╩──              └──────────────────────┘
  ion flux, loss of ΔΨ           threshold concentration needed
  requires high AMP:lipid ratio  (minimum inhibitory surface coverage)

  ③ TOROIDAL PORE (WORMHOLE) MODEL
  ══════════════════════════════════
  AMPs insert AND induce lipids
  to curve inward — pore lined
  by both peptides AND lipid heads

      ──│─╲ ╱─│──
        │  U  │       lipid monolayer
        │ pore│       curves continuously
      ──│─╱ ╲─│──     through pore wall
                      e.g., magainin, protegrin

  ┌───────────────────────────────────────────────────────────────────┐
  │  SECONDARY MECHANISMS beyond membrane disruption:                 │
  │  • Inhibit cell wall synthesis (nisin → lipid II binding)         │
  │  • Inhibit DNA replication (buforin II → enters, binds DNA)       │
  │  • Inhibit protein synthesis (PR-39 → ribosome inhibition)        │
  │  These do NOT always require pore formation — important caveat    │
  │  (Brogden 2005 argues membrane disruption may be secondary        │
  │  or even unnecessary for some AMPs)                               │
  └───────────────────────────────────────────────────────────────────┘

  EXAMPLES:
  Defensins   — mammals; broad spectrum; toroidal pore
  Magainins   — frog skin; toroidal pore model (Xenopus laevis)
  Cecropins   — insects; barrel-stave or carpet; first AMPs described
  Nisin       — Lactococcus lactis; lipid II binding + pore formation

Antimicrobial peptides kill bacteria through at least three membrane-disruption architectures, but a growing body of evidence shows that some AMPs operate through intracellular mechanisms entirely independent of pore formation, complicating a once-simple picture.

Diagram 5: Phage Lambda — Lytic vs. Lysogenic Decision

  BACTERIOPHAGE LAMBDA (λ) INFECTION OF E. coli
  ══════════════════════════════════════════════

  λ phage injects linear dsDNA (48,502 bp)
        │
        ▼
  cos sites allow circularization → circular λ DNA
        │
        ├──────────────────────┬────────────────────────────────┐
        ▼                      ▼                                │
  LYTIC CYCLE            LYSOGENIC CYCLE                        │
  ════════════           ═══════════════                        │
                                                                │
  Immediate early:       CII protein accumulates               │
  N, cro genes           (favored when:                        │
  expressed              • low MOI                             │
        │                • healthy cells                       │
        ▼                • low protease activity)              │
  Early genes:                  │                              │
  replication, recomb.          ▼                              │
        │               CI (λ REPRESSOR) made                  │
        ▼                      │                               │
  Late genes:            CI represses lytic genes              │
  head, tail,            CI activates int gene                 │
  holin, lysin                  │                              │
        │                       ▼                              │
        ▼               INTEGRASE (Int) catalyzes              │
  CELL LYSIS             site-specific recombination           │
  ~100 phage             attP × attB → λ integrates            │
  released               into E. coli chromosome               │
                                │                              │
                                ▼                              │
                         PROPHAGE state:                       │
                         replicates with host                  │
                         CI repressor maintained               │
                         SOS SIGNAL ──────────────────────────┘
                         (DNA damage → RecA activated)
                         RecA cleaves CI repressor
                         lytic cycle resumes → INDUCTION

  KEY REGULATORY PROTEINS:
  ┌───────────┬─────────────────────────────────────────────────┐
  │  PROTEIN  │  FUNCTION                                       │
  ├───────────┼─────────────────────────────────────────────────┤
  │  CI       │  Repressor; maintains lysogeny; represses PR,PL │
  │  Cro      │  Anti-repressor; represses CI; commits to lytic │
  │  CII      │  Activates PRE → CI synthesis; labile protease  │
  │           │  target — its stability = lytic/lysogenic switch│
  │  N        │  Antiterminator; allows early gene transcription│
  │  Q        │  Antiterminator; allows late gene transcription │
  │  Int      │  Integrase; site-specific recombination         │
  │  Xis      │  Excisionase; required for excision (induction) │
  └───────────┴─────────────────────────────────────────────────┘

The lambda phage lysis-lysogeny decision is a molecular switch governed by competing regulatory proteins where the stability of the CII protein — determined by host cell health — tips the balance between self-destruction and dormancy.

---

Key Takeaways

  1. The three domains of life are Bacteria, Archaea, and Eukarya, established by Carl Woese using 16S rRNA gene sequences. The 16S rRNA gene is ideal for phylogenetics because it is universally present, functionally constrained (so sequence changes accumulate slowly), and contains both conserved and variable regions. Archaea are prokaryotes but are more closely related to Eukarya than to Bacteria — a fact deeply counterintuitive before molecular phylogenetics.
  2. Peptidoglycan is unique to bacteria and is the target of β-lactam antibiotics. It consists of glycan chains of alternating NAG and NAM cross-linked by peptide bridges. β-Lactams (penicillin, ampicillin, etc.) are structural mimics of the D-Ala–D-Ala terminus of the stem peptide; they covalently inhibit the transpeptidase (penicillin-binding protein, PBP) that forms cross-links. Because no mammalian cell possesses peptidoglycan, β-lactams exhibit exquisite selective toxicity (Madigan et al., 2021, Chapter 27).
  3. Gram-negative bacteria possess an outer membrane containing lipopolysaccharide (LPS) on its outer leaflet. LPS acts as an endotoxin: the lipid A component triggers powerful innate immune responses (fever, septic shock). The periplasm between the inner and outer membranes is a distinct compartment housing degradative enzymes (including β-lactamases) and binding proteins for nutrient uptake — a compartment gram-positive bacteria lack entirely.
  4. Bacterial growth during the exponential (log) phase follows N(t) = N₀ · 2^(t/g), where g is the generation time. E. coli divides every ~20 minutes at 37°C in rich media; Mycobacterium tuberculosis every ~24 hours. The chemostat exploits the relationship μ = D (growth rate equals dilution rate) to hold cells in exponential phase indefinitely by making a single nutrient limiting — a powerful tool for controlled physiological experiments (Madigan et al., 2021, Chapter 5).
  5. The three mechanisms of horizontal gene transfer (HGT) — transformation, transduction, and conjugation — each move DNA by fundamentally different routes. Transformation requires DNA uptake from the environment (or electroporation in the lab). Transduction uses bacteriophage as a vector (generalized: random chromosomal fragments; specialized: flanking genes only, as in λ phage). Conjugation requires direct cell contact mediated by an F-factor-encoded pilus and transfers plasmid or, in Hfr strains, chromosomal DNA. The frequency of chromosomal gene transfer in interrupted Hfr matings was the original method used to map the E. coli chromosome.
  6. Transposable elements move by "copy and paste" (replicative transposition) or "cut and paste" (conservative transposition). IS elements are the simplest, encoding only transposase flanked by inverted repeats. Composite transposons (e.g., Tn10) consist of two IS elements flanking additional genes — often antibiotic-resistance genes. Transposition creates target-site duplications and is a major engine of antibiotic resistance spread. Site-specific recombination (as in λ phage integration via Int + attP × attB) differs from transposition in requiring specific sequences and precise exchange without duplication (Madigan et al., 2021, Chapter 12).
  7. The lytic-vs.-lysogenic decision of bacteriophage lambda is controlled by the relative stability of the CII protein. When CII accumulates (healthy host, low multiplicity of infection, low protease activity), it drives synthesis of the CI repressor, which represses lytic genes and allows integration into the host chromosome. When CII is degraded, Cro accumulates, represses CI, and commits the phage to the lytic cycle. Induction of a prophage requires RecA-mediated cleavage of CI repressor, typically triggered by host DNA damage (SOS response) — a deeply elegant coupling of phage fate to host physiology (Madigan et al., 2021, Chapter 6).
  8. Antimicrobial resistance arises by three main biochemical mechanisms: enzymatic inactivation, efflux pumps, and target modification. β-Lactamases hydrolyze the β-lactam ring (extended-spectrum β-lactamases, ESBLs, and carbapenemases represent escalating clinical threats). Efflux pumps (e.g., AcrAB-TolC in E. coli) are tripartite systems spanning the inner membrane, periplasm, and outer membrane that expel diverse antibiotics. Target modification includes methylation of the 23S rRNA ribosomal target by erythromycin resistance methylases (erm genes), and mutations in DNA gyrase/topoisomerase IV that confer fluoroquinolone resistance (Madigan et al., 2021, Chapter 27).
  9. Antimicrobial peptides (AMPs) are cationic, amphipathic molecules that selectively target bacterial membranes because bacterial membranes carry anionic phospholipids (phosphatidylglycerol, cardiolipin), while mammalian membranes are predominantly zwitterionic. Three membrane-disruption models exist: the barrel-stave model (AMPs aggregate into a transmembrane pore), the carpet model (AMPs coat the membrane and disrupt it detergent-like), and the toroidal pore model (AMPs and lipid headgroups together line a curved pore, as in magainins). Critically, not all AMPs kill by membrane disruption: buforin II enters cells and binds nucleic acids; PR-39 inhibits protein synthesis; nisin binds lipid II to block cell wall synthesis. The identity of the primary killing mechanism remains unsettled for many AMPs (Brogden, 2005).
  10. E. coli expression systems exploit defined promoters and their regulatory proteins. The T7 expression system uses T7 RNA polymerase (expressed from a chromosomal copy under lacUV5 control, induced by IPTG) to transcribe target genes from T7 promoters with very high efficiency — T7 RNAP is ~8× faster than E. coli RNAP. The tac promoter is a hybrid of the trp and lac promoters, stronger than either, and IPTG-inducible. Proteins that aggregate into inclusion bodies require denaturation (8M urea or 6M guanidinium) and refolding — a significant downstream challenge. Periplasmic expression via signal peptides (e.g., pelB, OmpA) enables disulfide bond formation and is preferable for many antibody fragments (Madigan et al., 2021, Chapter 12).
  11. Saccharomyces cerevisiae provides eukaryotic post-translational modifications inaccessible in E. coli, including N- and O-linked glycosylation, signal peptide cleavage, and proper disulfide bond formation in secreted proteins. The GAL1 promoter is strongly induced by galactose and repressed by glucose — a classic example of catabolite regulation. However, yeast produces high-mannose glycans that differ from human glycans, which is relevant when producing therapeutic glycoproteins (Madigan et al., 2021, Chapter 12).
  12. Oxygenic photosynthesis evolved once, in cyanobacteria, and was later transferred to eukaryotes via endosymbiosis. Cyanobacteria use two photosystems (PS I and PS II) and split water as an electron donor, releasing O₂. Anoxygenic photosynthesis (purple bacteria, green sulfur bacteria) uses only one photosystem and cannot split water; instead it uses H₂S, H₂, or organic molecules as electron donors. The evolution of oxygenic photosynthesis fundamentally transformed Earth's atmosphere — the Great Oxidation Event (~2.4 billion years ago) — and made aerobic life possible (Madigan et al., 2021, Chapter 14).
  13. Nitrogen fixation — reduction of N₂ to NH₃ — is catalyzed by the nitrogenase enzyme complex and requires 16 ATP and 8 electrons per N₂ molecule. Nitrogenase is irreversibly inactivated by O₂. Organisms solve this paradox in different ways: Anabaena forms heterocysts (differentiated cells with thickened walls and no PS II) to protect nitrogenase while conducting oxygenic photosynthesis in adjacent cells; Azotobacter uses very high respiration rates to scavenge O₂; Rhizobium retreats to root nodules where leghemoglobin buffers O₂ at low concentrations. No eukaryote can fix nitrogen — a fundamental ecological constraint (Madigan et al., 2021, Chapter 13).
  14. Fluoroquinolones (e.g., ciprofloxacin) inhibit DNA gyrase (topoisomerase II) and topoisomerase IV by stabilizing a covalent enzyme–DNA intermediate, trapping double-strand breaks. In gram-negative bacteria the primary target is gyrase; in gram-positive bacteria it is topoisomerase IV. Aminoglycosides (e.g., gentamicin, streptomycin) bind the 16S rRNA of the 30S ribosomal subunit, causing codon misreading and translational errors. Macrolides (e.g., erythromycin, azithromycin) bind the 23S rRNA of the 50S subunit at the peptide exit tunnel, blocking elongation. Each class thus attacks a distinct essential bacterial process — and each has correspondingly distinct resistance mechanisms (Madigan et al., 2021, Chapter 27).
---

References

  1. Michael T. Madigan, Kelly S. Bender, Daniel H. Buckley, W. Matthew Sattley, and David A. Stahl, Brock Biology of Microorganisms, 16th edition (Hoboken, NJ: Pearson, 2021).
  2. Kim A. Brogden, 'Antimicrobial Peptides: Pore Formers or Metabolic Inhibitors in Bacteria?' Nature Reviews Microbiology, vol. 3, no. 3 (2005), pp. 238–250. DOI: 10.1038/nrmicro1098